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Candida albicans is the most important fungal pathogen of humans. Transcript profiling
studies show that upon phagocytosis by macrophages, C. albicans undergoes a massive
metabolic reorganization activating genes involved in alternative carbon metabolism, including
the glyoxylate cycle, β-oxidation and gluconeogenesis. Mutations in key enzymes such as ICL1
(glyoxylate cycle) and FOX2 (fatty acid β-oxidation) revealed that alternative carbon metabolic
pathways are required for full virulence in C. albicans. These studies indicate C. albicans uses
non-preferred carbon sources allowing its adaptation to microenvironments were nutrients are
scarce. It has become apparent that the regulatory networks required for regulation of
alternative carbon metabolism in C. albicans are considerably different from the Saccharomyces
cerevisiae paradigm and appear more analogous to the Aspergillus nidulans systems. Wellcharacterized transcription factors in S. cerevisiae have no apparent phenotype or are missing
in C. albicans.
CTF1 was found to be a single functional homolog of the A. nidulans FarA/FarB proteins,
which are transcription factors required for fatty acid utilization. Both FOX2 and ICL1 were found
to be part of a large CTF1 regulon. To increase our understanding of how CTF1 regulates its
target genes, including whether regulation is direct or indirect, the FOX2 and ICL1 promoter
regions were analyzed using a combination of bioinformatics and promoter deletion analysis. To
begin characterizing the FOX2 and ICL1 promoters, 5’ rapid amplification of cDNA ends
(5’RACE) was used to identify two transcriptional initiation sites in FOX2 and one in ICL1. GFP
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reporter assays show FOX2 and ICL1 are rapidly expressed in the presence of alternative
carbon sources. Both FOX2 and ICL1 harbor the CCTCGG sequence known to be bound by
the Far proteins, hence rendering the motif as a putative CTF1 DNA binding element. In this
study, the CCTCGG sequence was found to be essential for FOX2 regulation. However, this
motif does not appear to be equally important for the regulation of ICL1. This study supports the
notion that although C. albicans has diverged from the paradigms of model fungi, C. albicans
has made specific adaptations to its transcription-based regulatory network that may contribute
to its metabolic flexibility.
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Chapter 1. Introduction
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BACKGROUND
Infection and pathogenesis of C. albicans
Clinical manifestations of C. albicans
C. albicans is considered the major fungal pathogen of humans [1]. Clinical
manifestations of C. albicans infections can be divided into two broad categories: relatively
benign superficial infections and severe, often life-threatening invasive infections. Susceptibility
to a particular type of Candida infection is frequently dictated by the immunologic status of the
host, with invasive infections almost always affecting immunocompromised patients. However,
invasive candidiasis is becoming an increasing concern in critically ill, non-immunosuppressed
patients [2,3].
Superficial candidiasis
According to Pfaller and Diekema, 2010 [4], C. albicans is the etiological agent of more
than 90% of cases of superficial infections of cutaneous and mucosal membranes. Cutaneous
candidiasis is frequently seen at the intertrigos (i.e. bending creases between toes or fingers,
under the breast or armpit) and is triggered by maceration of the skin, heat, humidity and
obesity [5]. In healthy neonates and young infants, diaper dermatitis is the main clinical
manifestation caused by Candida. Clinical manifestations in mucosal surfaces primarily include
oropharyngeal candidiasis (oral thrush) and vulvovaginal candidiasis (VVC) in women. Oral
infection with Candida is associated with several risk factors. Among these are the two
extremes of age (neonates and people older than 65 years), the use of broad-spectrum
antibiotics and prosthetic dentures [6]. Systemic conditions including diabetes mellitus,
immunosuppressive therapy and radiation therapy for head and neck cancer are known to be
predisposing factors for oropharyngeal candidiasis [7-9]. In addition, patients who have
suppressed T-cell function are at high risk for oropharyngeal candidiasis. This is indicated by
the fact that oropharyngeal candidiasis is observed in 7%–48% of people with human
immunodeficiency virus-positive (HIV+) infection and in over 90% of AIDS patients [10,11] [12].
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Infection of vaginal mucosa with Candida is associated with pregnancy and the use of
contraceptives [13], as well as non-hormonal factors such as antibiotic use and diabetes
mellitus [14] . Studies indicate up to 75% of women suffer from vulvovaginitis [15]. Only those
that experience recurrent vulvovaginal candidiasis (RVVC) are thought to have an underlying
innate immune deficiency [16]. Chronic mucocutaneous candidiasis is one of the most serious
superficial infections involving colonization of both mucosal and skin surfaces by Candida spp.
(especially C. albicans) and it develops in patients with impaired T-cell function where
inadequate production of cytokines leads to inefficient cell mediated immunity [17].
Invasive candidiasis
Invasive candidiasis refers to Candida infections that occur once epithelial tissues are
breached. Blood-stream infections known as candidemia can lead to disseminated or systemic
candidiasis, which is characterized by the hematogeneous spread to one or more vital organs
such as the kidney and liver [18]. In fact, disseminated candidiasis is the most severe clinical
manifestation of Candida species [4,19]. Candida species are recognized as the fourth leading
cause of nosocomial bloodstream infections in the U.S. and are surpassed only by Staphylocci
[19]. Mortality rates attributed to candidemia or invasive candidiasis range from 10% to 49% [4].
In the United States, C. albicans causes most candidemias (50-60%), followed by Candida
glabrata, Candida parapsilosis, Candida tropicalis and Candida krusei [20]. Risk factors for
invasive candidiasis are diverse [21] and include candidal colonization [22], prolonged intensive
care unit (ICU) stay [19], broad-spectrum antibiotics, chemotherapy-induced neutropenia
[23,24], extensive surgery, organ transplantation, and prolonged use of intravascular catheters,
which are substrates for biofilm formation [4,25].
Diagnostic methods to detect candidiasis
Early diagnosis of invasive candidiasis is difficult due to the non-specific symptoms
presented by fungal infections, which are often mistaken to be of bacterial origin. Slow
diagnosis is mainly attributed to the lack of sensitive and specific diagnostic methods [2,21,26].
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Traditional microbiological methods including microscopic detection of Candida and its isolation
from a normally sterile site such as blood have been used. However, early diagnosis using
these methods has been hampered by the inability to differentiate between different Candida
species and false-negative blood culture results that only become positive late in the course of
infection. Although a histopathological approach is a reliable method to diagnose systemic
infection, it does not differentiate between species and the requirement of tissue biopsy is not
feasible in some critically ill patients.
In an attempt to circumvent these problems, researchers have also developed non
culture-based methods that target fungal metabolites, antigens, antibodies and nucleic acid.
Serological tests have been reported to be successful at detecting several antigens including
mannan (the major cell wall protein of C. albicans) and the fungal specific β-1,3-glucan (required
for cell wall synthesis). However, it may be difficult to interpret serological results since the
levels of circulating antigens can vary based on the host’s immunologic status, and in some
cases antigens are detected in healthy individuals due to Candida colonization. Detection of
fungal antibodies as a criterion for disease has been less useful also due to Candida
colonization in healthy individuals, as well as to the absence of detectable antibody in
immunocompromised patients with candidemia or invasive candidiasis. Although, the fungal
metabolite D-arabinitol produced by most medically important Candida species can be
successfully identified in serum or urine of some patients, metabolites similarly to antibodies are
rapidly cleared from circulation and may not be readily detected. Molecular biological methods
such as PCR-based assays that identify fungal nucleic acid have proved to be useful for early
and accurate disease diagnosis. However, most molecular biological methods have not been
standardized and are not yet available in all clinical settings. Although, some diagnostic
methods have been proven better than others at detecting candidemia or invasive candidiasis,
all pose limitations. Therefore a combination of microbiological, serological, histopathological,
and molecular biological tests may be required to have an early and accurate diagnosis [26].
4

Current Antifungal agents
In addition to the limitations posed by the current diagnostic tools, Candida bloodstream
infections remain problematic in clinical settings due to a lack of treatment options, a delayed
administration of therapy, inadequate dose or duration of treatment, as well as drug-related
toxicity and the use of a drug to which the Candida species is resistant [4]. The administration of
proper antifungal treatment early in the course of infection is essential to decrease the mortality
associated with invasive candidiasis in clinical settings. For example, a study done by Garey et
al., 2006, showed the mortality rate in patients with candidemia was less than 15% in patients
treated within 24 hours of a positive blood culture, whereas a mortality rate of 41% was
observed for patients that received treatment on day 3 or later [27]. In the ICU, Candida
species are the third most common cause of nosocomial bloodstream infections [19]. This is in
part due to the lack of effective antifungal agents currently available. Antifungal drugs can be
grouped into four main categories: polyenes, ergosterol biosynthesis inhibitors, echinocandins,
and nucleic acid synthesis inhibitors [28]. Polyenes are designed to target ergosterol, a sterol
that is absent in humans, but is essential for fungal cell membranes and growth. The modus
operandi of polyenes is to bind ergosterol and create pores in the plasma membrane which
allow cell contents to leak, thereby resulting in cell death. The azoles, which are the most
important class of ergosterol biosynthesis inhibitors, function by inhibiting the Erg11 enzyme
which leads to the depletion of ergosterol in the cell membrane. Echinocandins have been
recently developed and belong to a category of antifungal drugs that work by inhibiting the β1,3-glucan synthase, an enzyme that is required for cell wall biosynthesis. Finally, the last class
of antifungal drugs which inhibits nucleic acid synthesis is represented by 5-flucytosine.
Cytosine deaminase (absent in mammalian cells) converts 5-flucytosine to 5-fluorouracil, which
specifically interferes with fungal nucleic acid synthesis [28].

5

Therapeutic options
Treatment options for fungal infections vary substantially. Current treatments have to
take into consideration the site and type of infection, the patient’s immune status, underlying
disease, and risk factors for infection, as well as the specific species of Candida responsible
and whether it exhibits antifungal drug resistance. Superficial infections are usually self-limited
in non-immunocompromised patients and are readily treated with basic hygiene measures [2]
and topical antifungal treatment (i.e. clotrimazole, miconazole, or nystatin), whereas persistent
and refractory infections are treated with systemic treatment (i.e. ketoconazole, fluconazole, or
voriconazole) [5,29-31]. Current treatment options for candidemia include the azoles
(fluconazole and triazoles), echinocandins and the polyenes [32,33]. Treatment with
amphotericin B has been the gold standard for years, yet some studies have shown large doses
of amphotericin B are associated with nephrotoxicity [34]. When required, the more expensive
amphotericin B lipid formulations are used. Caspofungin, micafungin and anidulafungin are the
only echinocandin agents approved for clinical use [33] and are currently recommended for the
treatment of candidemia or invasive candidiasis. However, echinocandins have also been
associated with hepatic toxicity [35].

Fluconazole is considered the first-line agent in non-

neutropenic patients with candidemia or invasive candidiasis as it is conveniently administered
and has few side effects [32].
Antifungal resistance
As mentioned previously, the use of antifungal agents can also be limited by antifungal
resistance. Antifungal resistance is a complex phenomenon that involves several mechanisms.
For example, resistance to azole drugs such as fluconazole has been well documented and can
be caused by alterations in sterol biosynthesis, mutations in the drug target enzyme, sterol 14αdemethylase (14DM), increased expression of the ERG11 gene which encodes 14DM, or
overexpression of genes that code for membrane transport proteins of the ABC transporter
(CDR1/CDR2) as well as the major facilitator (MDR1) superfamilies [28,36]. Resistance to 56

flucytosine is known to occur as a result of specific mutations in cytosine deaminase, whereas
resistance to Amphotericin B is less clear [28]. Administration of ineffective antifungal therapy
can greatly impact the outcome of Candida infections leading to an increase in hospital
mortality. As mentioned above, the efficacy of antifungal treatments has been complicated by
multiple factors including inadequate treatment, drug-related toxicity and increasing antifungal
resistance. Therefore, the development of novel effective antifungal agents is needed.
Commensal colonization
C. albicans is an opportunistic pathogen with no known environmental reservoir, and
instead is found as a harmless commensal of the mammalian microflora [1]. Skin and mucosal
surfaces including the gastrointestinal tract and oropharynx, as well as the vaginal canal and
vulva of healthy women, are commonly colonized with Candida. C. albicans has been reported
as the predominant Candida species, and as an opportunistic pathogen it has the potential to
cause infection at any anatomical site [1]. Different studies have revealed oral asymptomatic
Candida carriage rates vary among different age groups, and range between 45-65% in healthy
children [1], 68% in healthy adults [37] and up to 88% in the elderly [38]. Asymptomatic Candida
carriage rates have been estimated to be over 50% in the gastrointestinal tract and up to 25%
for vaginal areas [1].
Virulence factors of C. albicans
The ability of C. albicans to transition from a harmless commensal of the microflora to a
pathogen depends on C. albicans classical and non-classical virulence factors, as well as a
competent host immune system [39]. The initial colonization of mucosal and cutaneous
membranes requires classical virulence factors, including adhesins and extracellular hydrolytic
enzymes [40,41]. Adhesins such as the agglutinin-like proteins (Als family of proteins) [42] and
Hwp1 (hyphal wall protein 1) [43] are not only involved in adhesion and colonization of host
tissues, but are also important for biofilm formation [44,45]. The best characterized extracellular
hydrolytic enzymes are the secreted aspartyl proteinases (SAPs), which are known to be
7

differentially expressed based on the host niche encountered and the stage of infection [46,47].
For example, SAP1, SAP3, and SAP6-SAP8 expression is correlated with adhesion to the
vaginal epithelium during vaginitis, whereas SAP1, SAP3, SAP4, SAP7, and SAP8 expression
were found to be relevant in the oral cavity during oropharyngeal candidiasis [46]. Phenotypic
switching is a phenomenon that is also believed to contribute to C. albicans pathogenesis.
According to Soll, 2002 [48], phenotypic switching is a process that affects different cellular
properties including morphology [49], adhesion [50] and antigenicity [51] among others. The
white–opaque system in strain WO-1 in which smooth, white colonies switch to flat, opaque
colonies [52] is the most studied type of phenotypic switching and has been observed in strains
isolated from patients with Candida infections including invasive candidiasis [53]. Host factors
that confer protective immunity against pathogens are essential to maintain C. albicans as a
harmless commensal and although phagocytes are usually effective at clearing fungal
infections, several studies have revealed C. albicans has the ability to overcome host defenses
by immune evasion or modulation strategies that allow intracellular survival of the fungus [54].
For example, a study using mutant strains that are lacking O-linked and N-linked mannans
demonstrated the importance of cell surface glycosylation to avoid phagocytosis of C. albicans
[55]. If phagocytosis cannot be avoided, C. albicans resorts to other strategies including the
manipulation of phagosome maturation and the ability to survive and replicate intracellularly
[56]. One of the key virulence factors of C. albicans is its ability to switch from yeast to filaments
in the form of pseudohyphae or hyphae, which allow macrophage destruction and the
subsequent escape of the fungus [57,58]. The importance of this morphological transition to
establish infection has been further highlighted by mice studies, which show that nonfilamentous C. albicans mutants are avirulent [58].
Interaction of C. albicans with the host’s immune response
Host innate and adaptive immune responses are responsible for conferring protective
immunity against C. albicans infections [25]. Adaptive immune responses counteract infections
8

at specific sites and consist of humoral and cell-mediated immunity. For example, humoral
immune mechanisms are activated in response to cutaneous infections, whereas cellular
immune responses are required against mucosal infections such as oropharyngeal candidiasis
[10]. In contrast, the predominant protective mechanism against invasive candidiasis is the
innate branch of the immune system. Innate immunity consists of physical barriers such as the
skin and mucous membranes, as well as professional phagocyte populations including
neutrophils, monocytes/macrophages and dendritic cells whose primary function is to eliminate
pathogens [59]. The fungicidal effects of these cells not only depend on the site of infection, but
also on the type of cell encountered [59,60]. Phagocytes engulf pathogens forming an
intracellular vesicle or phagosome that progressively fuses with early and late endosomes, and
the lysosome to form the phagolysosome. Inside the phagolysosome, pathogens are exposed
to an acidic environment, microbicidal molecules and limited nutrients [54]. Once within the
phagolysosome, the pathogen is killed via oxidative (e.g. reactive oxygen species generated by
NADPH-oxidase and myeloperoxidase) [61] and non-oxidative mechanisms.
Types of phagocytes
Neutrophils are the first immune cells to be recruited from the bloodstream to sites of
infection, and their main function is to kill invading pathogens via intracellular and extracellular
mechanisms [62]. Studies have shown that neutrophils prevent the transition of yeast to hyphae
[63] and are the only cell type in the bloodstream that inhibits C. albicans germ tube formation
[64]. Furthermore, activated neutrophils kill C. albicans yeast and hyphal forms using neutrophil
extracellular traps (NETs), which are fibers that consist of granule proteins and chromatin [65].
Based on the importance of neutrophils in clearing infections, it is not surprising that patients
with reduced levels of neutrophils (i.e. neutropenia) are more susceptible to disseminated
candidiasis [23,24,66]. Unlike neutrophils, monocytes are recruited to infected tissues where
they differentiate into macrophages and dendritic cells. Although it appears the microbicidal
potential of macrophages is less elaborated than that seen in neutrophils [67], macrophages
9

also have the ability to act as antigen presenting cells and act in concert with neutrophils to
clear infections [68]. Recently, dendritic cells have been shown to be important for phagocytosis
of both yeast and hyphal cells of C. albicans leading to the activation of the adaptive immune
response depending on the morphotype encountered [69]. In response to hyphal forms, murine
dendritic cells lead to the activation of the TH2 responses, whereas TH1 responses were
activated as a result of yeast cells [69]. Therefore, dendritic cells are important for linking innate
immunity to adaptive immune responses.
Transcriptional responses to phagocytes
A plethora of studies have focused on virulence factors such as adhesins and hydrolytic
enzymes, as they are important for the establishment of C. albicans infections. However, less
emphasis has been given to the acquisition of essential nutrients required for growth and
survival within diverse host niches. Colonization of the gastrointestinal tract has been
considered as a pre-requisite for Candida infection and it is believed that infection arises as a
result of changes in the host’s microflora and immune system [24]. Although C. albicans
encounters an abundant source of nutrients within the human microflora, nutrient acquisition is
limited by competing microorganisms. In order for C. albicans to grow and maintain systemic
infections, it must be able to undergo metabolic adaptations to different changing microenvironments within the host. According to Koh et al., 2008 [24], alterations in the microflora as
a result of antibiotic treatment and chemotherapy-induced neutropenia allows epithelial invasion
and dissemination of C. albicans cells. The ability of C. albicans to disseminate via the bloodstream is in part due to the acquisition of nutrients available in the blood. Glucose is the
preferred carbon source for yeast including C. albicans. Blood glucose levels within the host
range between 6 and 8 mM [70] offering the nutrition required for C. albicans to grow and
maintain systemic infection. However, nutrient availability is scarce once C. albicans cells are
internalized by phagocytic cells. Several genomic transcript profiling studies have revealed C.
albicans uses complex transcriptional programs that are significantly different in response to
10

blood [64,71], tissue [72] and upon phagocytosis by neutrophils [73] or macrophages [57].
These studies indicate that glucose, which is the preferred carbon source for C. albicans, is the
major carbon source in plasma and tissue, but is limiting inside the phagosome. In order to
survive intracellularly, C. albicans must be able to assimilate non-preferred carbon sources.
Differential display technology was used by Prigneau et al., 2003 to identify C. albicans genes
that are differentially expressed in response to phagocytosis [74] and found most of the genes
induced were involved in carbon metabolism. A transcript profiling approach was used by
Lorenz et al., 2004 to study the interaction of C. albicans with mammalian macrophages [57].
The transcription profile observed is similar to nutrient starvation, where induction of alternative
carbon metabolism with a concomitant downregulation of translation and glycolysis takes place
suggesting C. albicans is able to use multiple non-preferred carbon sources during macrophage
infection [57]. This study revealed that upon phagocytosis, C. albicans displays a complex
transcriptional response characterized by an early and a late phase (Figure 1-1). During the
early phase (within 1 hr), C. albicans undergoes a remarkable reprogramming of transcription
(>500 genes regulated) [57]. In addition to the carbon metabolic response, activation of C.
albicans-specific genes, oxidative stress responses, DNA damage repair, peptide utilization,
and arginine biosynthesis was seen during the early phase. The metabolic shift early in the C.
albicans-macrophage interaction allows the morphogenetic switch from yeast to hyphae, which
promotes escape into the bloodstream. In the late phase, C. albicans successfully resumes
rapid glycolytic growth [57].
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Figure 1-1. C. albicans interaction with macrophages.
Upon phagocytosis, C. albicans survives inside macrophages, transitions from yeast to hyphae,
and pierces the macrophage allowing its escape. Genetic reprogramming of transcription
analogous to changes seen during carbon starvation is part of the early response against host
innate immunity. Images courtesy of M.C. Lorenz.
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Figure 1-1. C. albicans interaction with macrophages.
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Alternative carbon metabolism in C. albicans
Several studies have indicated that the metabolic flexibility displayed by C. albicans is
important for its ability to adapt to diverse host niches. Therefore, it is important to increase our
understanding of the regulatory networks governing carbon metabolism in C. albicans. Survival
within the phagosome requires the production of energy and catabolites necessary for the
synthesis of complex macromolecules. In the absence of glucose, C. albicans represses
glycolysis and activates alternative carbon metabolic pathways. A description of alternative
carbon metabolic pathways which include the glyoxylate cycle, gluconeogenesis, and βoxidation is shown in Figure 1- 2 [75].

Fatty acids such as oleate (an unsaturated 18-carbon

fatty acid) are degraded by a series of β-oxidation steps that result in the production of the key
intermediate acetyl-CoA [76-78]. The glyoxylate cycle, which bypasses the tricarboxylic acid
(TCA) cycle, is required for the net conversion of acetyl-CoA to oxaloacetate allowing the
generation of glucose via gluconeogenesis [79]. Two carbon compounds such as acetate,
ethanol, lactate, and some amino acids are converted to acetyl-CoA and incorporated via the
glyoxalate cycle. Compounds such as malate, citrate, and succinate can replenish TCA cycle
intermediates. Furthermore, additional substrates such as glycerol and other amino acids are
assimilated through gluconeogenesis. According to Hynes et al., 2007, filamentous fungi use a
vast array of gluconeogenic substrates in comparison to S. cerevisiae [11].
Several lines of evidence indicate glucose availability is limited within the phagosome,
and the utilization of multiple non-fermentable carbon sources is critical for C. albicans growth
and survival. This observation is supported by microarray data generated by our laboratory
[57]. The transcript profiles of phagocytosed cells show induction of genes encoding key
enzymes involved in alternative carbon metabolic pathways. For example, ICL1 (glyoxylate
pathway isocitrate lyase) and FOX2 (multifunctional protein of β-oxidation) are induced 33.6and 44-fold, respectively (Figure 1-2). [57]. Mutations affecting key enzymes of alternative
carbon metabolic pathways have varying degrees of influence on C. albicans virulence. In
14

2001, using whole-genome microarray analysis, Lorenz and Fink showed that C. albicans
glyoxylate cycle genes (isocitrate lyase, ICL1 and malate synthase, MLS1) are induced during
phagocytosis, and that disruption of ICL1 decreased C. albicans virulence in a mouse model of
disseminated candidiasis [80]. Other independent studies have agreed with this finding [81,82].
In addition, Ramirez and Lorenz, 2007 demonstrated that strains deficient in FOX2 show a
moderate, but significant decrease in C. albicans virulence [75]. It is clear that upon
phagocytosis, C. albicans encounters multiple non-preferred carbon sources such as acetate
and fatty acids. However, the exact range of substrates available during infection is unknown. In
2003, Barelle et al. used green fluorescent protein (GFP) fusions to examine the activity of key
genes involved in glycolysis, gluconeogenesis and the glyoxylate cycle [81]. In vitro and ex vivo
experiments revealed genes required for gluconeogenesis (PCK1) and glyoxylate cycle (ICL1)
had a prominent role during macrophage and neutrophil infection, whereas the subsequent
progression of systemic disease was dependent upon the activation of glycolytic genes [81]. In
addition, by using an in vivo infection model, they were able to show that within infected tissues,
different subpopulations of cells encounter distinct micro-environments that vary on nutrient
availability. Altogether these studies showed that C. albicans regulates central carbon
metabolism based on the host niche encountered and on the stage of infection. Overall, it was
concluded that the metabolic flexibility displayed by C. albicans is critical for survival and
disease progression.
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Figure 1-2. Induction of alternative carbon metabolism in C. albicans
Upon phagocytosis of C. albicans by macrophages there is an upregulation of key genes
involved in alternative carbon metabolism. These metabolic pathways converge on the key
intermediate, acetyl-CoA to provide sufficient energy and catabolite products allowing the
survival and escape from phagocytic cells (Ramirez and Lorenz, 2007).
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Figure 1-2. Induction of alternative carbon metabolism in C. albicans
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Regulation of alternative carbon metabolism in yeast, filamentous fungi and C. albicans
A search for carbon regulators in C. albicans was done in our laboratory through
sequence and homology studies based on two model fungi: Saccharomyces cerevisiae and the
filamentous fungi, Aspergillus nidulans [75,83]. It has become apparent that the transcriptional
regulatory networks governing alternative carbon metabolic pathways in C. albicans are
considerably different from S. cerevisiae, and appear more analogous to A. nidulans. The major
regulators of carbon metabolism have been characterized in S. cerevisiae (reviewed in
reference [84]). Many of them belong to the Gal4 family and are zinc binuclear cluster proteins
[85] characterized by the presence of a fungal-specific zinc cluster motif, Zn(II)2Cys6 (CysX2Cys-X6Cys-X5−12Cys-X2Cys-X6−8Cys) that is found within the DNA-binding domain [86].
Regulation of carbon metabolism involves glucose repression and induction by specific carbon
sources. In the presence of glucose, Mig1, a C2H2 zinc finger protein [87], targets the global
repressor complex Tup1p/Ssn6p to the promoters of genes involved in alternative carbon
metabolism. In conditions were glucose has been depleted, Mig1 targets are derepressed
allowing expression at basal levels. This derepression is mediated by the Snf1 kinase, which
phosphorylates Mig1 promoting its export from the nucleus to the cytoplasm [88], thus allowing
positive regulators such as Cat8, Sip4, Adr1, Oaf1 and Pip2 to induce expression of alternative
carbon metabolic genes. Cat8 is a transcription factor regulated by gluconeogenic substrates
such as acetate, glycerol, and fatty acids. It activates genes involved in the glyoxylate cycle
(e.g. Icl1) [89] and gluconeogenesis (e.g. Fbp1) [90] by binding to a carbon source-responsive
element (CSRE) found in their promoters. Expression of the transcription factor, Sip4 is
dependent on Cat8 activation [91], and in turn Sip4 contributes to the activation of genes
involved in the glyoxylate pathway and gluconeogenesis by binding to their CSRE [92]. The
transcription factors Oaf1 and Pip2 bind as a heterodimer to oleate response elements (OREs)
found within the promoters of β-oxidation and peroxisomal genes [77,93]. However, there is
evidence that some targets (e.g Fox2) are regulated by Oaf1 homodimers in the absence of
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Pip2 [94]. The direct binding of oleate to the ligand binding domain of Oaf1 leads to its
activation, whereas activation of Pip2 is mediated by the Oaf1/Pip2 heterodimer [95]. In addition
to its role as an alcohol dehydrogenase regulator [96], Adr1 activates Pip2 heterodimer for
maximal inducibility of target genes in response to oleate [97].
In A. nidulans, glucose repression is mediated by CreA, the Mig1 homologue [98]. FacB
is a major regulator of genes that encode enzymes of acetate metabolism including isocitrate
lyase (acuD) and malate synthase (acuE) [99,100]. Sequence analysis revealed FacB is similar
to Cat8 and Sip4 of S. cerevisiae, but genetic studies showed facB mutations affect growth on
acetyl-CoA sources, but not on gluconeogenic substrates indicating that FacB is a specific
regulator of the glyoxylate cycle and not gluconeogenesis [101,102]. To activate genes involved
in gluconeogenesis, A. nidulans instead employs two transcription factors, AcuK and AcuM
[103,104]. Mutations in AcuK and AcuM affect growth on gluconeogenic substrates and result in
loss of induction of the gluconeogenic genes acuF, encoding phosphoenolpyruvate
carboxykinase, and acuG, encoding fructose-1,6-bisphosphatase[103,104]. Furthermore, A.
nidulans lacks the Oaf1/Pip2 heterodimer which is important for activation of β-oxidation and
peroxisome biogenesis in S. cerevisiae. In A. nidulans, the FarA and FarB proteins are
responsible for activating not only β-oxidation and peroxisomal genes, but also those involved in
the glyoxylate cycle [105]. In addition, Northern blot analysis has shown that deletion of the farA
gene abolishes induction by fatty acids, both short-chain (e.g. butyrate) and long-chain (e.g.
oleate), while deletion of the farB gene eliminates only short-chain fatty acid induction [105].
Regulatory networks governing alternative carbon metabolic pathways in C. albicans
have diverged from S. cerevisiae and appear to be more similar to those seen in A. nidulans.
There are clear homologs of Snf1, Mig1, Cat8 and Adr1 in C. albicans. In C. albicans, SNF1 is
essential [106], and although there are some regulatory differences, overall MIG1 has a similar
function in both species [107]. Furthermore, data from our lab show the roles of Cat8 and Adr1
are not conserved in C. albicans despite having high sequence homology to the S. cerevisiae
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counterparts [83]. C. albicans is analogous to A. nidulans in that it also lacks Oaf1 and Pip2,
and instead CTF1 is a single functional ortholog of the FarA/FarB proteins [83]. CTF1 was
initially isolated from the plant pathogen Fusarium solani for its ability to induce cutinase genes
in the presence of cutin monomers (hydroxylated fatty acids), and was designated as cutinase
transcription factor 1α [108]. Studies done in Fusarium revealed that a palindrome rich site with
a 6-bp core (CCTCGG) is required for DNA binding by CTF1α in the presence of fatty acids
[108]. A single CCTCGG motif was shown to be required for binding of both FarA and FarB of A.
nidulans [105]. In the presence of inducer, FarA/B positively regulates genes involved in fatty
acid catabolism. FarA was also shown to have a repressor function in the absence of inducer.
The exact molecular mechanisms have not been elucidated, but competition for the binding
motif by the induced and non-induced FarA as well as a possible post-translational regulation
has been suggested. According to Hynes et al., 2006, the CCTCGG motif is also conserved in
other fungal species, but it is not conserved in genes involved in S. cerevisiae fatty acid
catabolism [105]. C. albicans CTF1 shares 39.1% identity with FarA, 27.4% with FarB, and 28%
with FsCTF1α [83]. Phenotypic assays of a strain lacking CTF1 show a considerable growth
defect in various fatty acids including oleate indicating that CTF1 is required for fatty acid
degradation. In addition, several key enzymes including ICL1 and FOX2 are under positive
CTF1 regulation. Although these data indicate CTF1 is a regulator of fatty acid degradation,
knowledge of how CTF1 directly regulates its target genes is limited.
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SIGNIFICANCE OF THE STUDY
C. albicans is typically carried as a relatively harmless commensal, but has the potential
to cause a broad range of infections. Superficial mucocutaneous infections can affect relatively
healthy individuals, whereas systemic infections pose a higher risk to immunodeficient
individuals or critically ill patients. C. albicans is the causal agent of more than 50% of
candidemias and is considered the major fungal pathogen of humans [1]. It can infect virtually
any anatomical site, reflecting its remarkable plasticity in adapting to diverse niches within its
host. The high mortality associated with disseminated candidiasis is attributed to several factors
including poor diagnosis and inadequate or delayed treatment. In addition, the management of
Candida infections in clinical settings is hindered by drug toxicity and increasing drug
resistance. Therefore, there is a need for novel therapeutic approaches that target unique
aspects of fungal biology. Ideally, new antifungal agents should target processes that are not
present in humans (e.g. glyoxylate cycle ) or are highly divergent between the host and the
pathogen (e.g. fatty acid β-oxidation)[77]. Most antifungal drugs currently available target the
fungal cell membrane and cell wall, but metabolic pathways are also suitable candidates for the
development of new drugs [109,110]. The knowledge about nutrient acquisition and essential
metabolic pathways used by pathogenic fungi is critical for the development of novel disease
control strategies.
Several studies indicate that there are sufficient levels of glucose in the bloodstream,
which allows rapid growth and dissemination, whereas C. albicans intracellular survival is
dependent upon the utilization of alternative carbon sources such as acetate and fatty acids.
The ability to use a wide variety of gluconeogenic substrates may be an important aspect of C.
albicans pathogenicity. Increasing evidence indicates that upon phagocytosis, C. albicans
undergoes a complex transcriptional response that leads to the upregulation of genes involved
in alternative carbon metabolism, including the glyoxylate cycle, gluconeogenesis and βoxidation, and a downregulation of the translational machinery [57,64,71]. Mutations affecting
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key enzymes of alternative carbon metabolic pathways attenuate the virulence of C. albicans,
highlighting the importance of central carbon metabolism for the establishment of C. albicans
infections. Evidence from genome-scale analyses in multiple fungi suggests metabolic
processes are under a global coordination that is mediated in great part by transcriptional
regulation [111]. This underscores the significance of elucidating transcriptional regulatory
networks that govern alternative carbon metabolism. However, knowledge of the strategies
employed by C. albicans to control the expression of carbon metabolic genes is limited. Studies
by Ramirez and Lorenz, 2009 [83], have started to elucidate the role of CTF1 in C. albicans.
CTF1 is required for fatty acid degradation and is required for the co-regulation of fatty acid βoxidation, FOX2 and glyoxylate cycle, ICL1 genes. Microarray data indicate CTF1 has a large
regulon (217 genes), and many of the genes under CTF1-dependent regulation have unknown
functions [Ramírez, MA and Lorenz, MC unpublished data]. The fact that CTF1 regulates so
many genes underscores its importance as a transcriptional regulator and warrants further
studies on its mode of regulation. The expression pattern of genes is in great part determined by
short promoter sequences or motifs that are binding elements for specific transcription factors.
Hence, identifying and characterizing regulatory motifs within CTF1-dependent genes, FOX2
and ICL1 is central in understanding regulatory networks that control alternative carbon
metabolism.
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Chapter 2. Materials and Methods
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Strains, growth, and transformation
Table 2-1 lists all the C. albicans strains used for these studies, which are based on the
parent wild-type strain SC5314 and its auxotrophic derivative CAI4-F2 (URA-) [112]. The strains
were maintained on standard yeast media [113], including YPD (1% yeast extract, 2% peptone,
2% dextrose) and YNB (0.17% yeast nitrogen base, 0.5% ammonium sulfate). To manipulate
the expression of target proteins, YNB was supplemented with 2% glucose, 2% potassium
acetate, or oleic acid solubilized with Tween 20 (0.5% oleic acid, 1% Tween 20). CAI4-F2 and
ctf1Δ/Δ (MRC39) strains were transformed using the electroporation method as described by
Reuss et al., 2004 [114].
Table 2-2 lists all the plasmids used for these studies. DNA manipulations including
plasmid isolation, PCR, restriction digestion, cloning, and gel electrophoresis were performed by
standard methods [115]. Genomic DNA was isolated by using the glass bead disruption method
[116]. Automated DNA sequencing was performed by Genewiz Inc. (Southplain, NJ).
Escherichia coli DH5α strain was used as a host for plasmid constructions and propagation. E.
coli was grown on selective Ferric Broth (FB) liquid or agar growth media containing the
appropriate antibiotics, ampicillin (100 μg/ml) or nourseothricin (100 μg/ml) at 37°C. A total of 5
μl of ligation products or purified plasmid DNA was used to transform chemically competent
JS238 E. coli cells [115].
Construction of C. albicans strains
The FOX2 and ICL1 promoters were dissected via promoter deletion analysis using the
yeast enhanced green fluorescent protein (GFP) based on the pGFP vector described by
Barelle et al., 2004 [117]. Constructs for GFP transcriptional reporters were made in which the
expression of GFP is driven by 1000 bp promoter fragment or by systematic 5’ promoter
deletions immediately upstream of the translational start codon (ATG). To create the GFP
reporter constructs, promoter-specific primer pairs containing a KpnI site in the 5’ oligo and an
XhoI or HindIII site in the 3’ oligo were designed. The oligonucleotides listed in table 2-3 were
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used to PCR amplify each DNA fragment to be inserted into the pGFP vector previously
digested with KpnI/ XhoI or HindIII. A promoter-less pGFP vector lacking GFP activity was used
as a negative control, whereas a 1000 bp ACT1 promoter- pGFP vector driving constitutive GFP
expression was used as a positive control. Each plasmid was linearized with StuI, gel purified,
and transformed via the Candida electroporation protocol [114] to the wild-type strain (CAI4-F2)
and the CTF1 mutant strain, ctf1∆/∆. Transformants were selected on SD-URA plates and
grown at 30°C for 3 days. All constructs were incorporated at the phenotypically neutral RPS10
locus and correct integration was confirmed by PCR analysis of genomic DNA [75,118,119].
Overlap extension PCR
Overlap extension PCR as described by Heckman and Pease, 2007 [120] was used for
deletion and site-directed mutagenesis of DNA sequences. Briefly, two separate PCRs that
create overlapping gene segments were performed using internal primers designed to delete
the 6 bp core CCTCGG motif from the FOX2 promoter, as well as to introduce nucleotide
substitutions in the same motif (CCTCGG  CATCAG). In a subsequent PCR, flanking primers
with KpnI/ XhoI were used to generate the full-length product. The product was then inserted
into the pGFP vector (KpnI/ XhoI) and incorporated into the CAI4-F2 and ctf1∆/∆ as described
previously.
RNA extraction and Northern Blot Analysis
C. albicans strains were grown overnight in YNB media supplemented with 2% glucose
and subcultured to an OD600 of ~ 0.5 in the same media. The cultures were grown at 30°C to
mid-log phase (OD600 of ~1.0), collected by centrifugation and washed twice with double
deionized water (ddH2O). The cells were resuspended in YNB media supplemented with one of
three carbon sources: glucose (2%), potassium acetate (2%) or 0.5% oleic acid, 1% Tween 20
and incubated for 1 hour at 30°C. The cells were again collected by centrifugation and washed
twice with ddH2O. The cell pellet was frozen in dry ice and ethanol for storage at -80 °C. Total
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RNA was extracted from C. albicans using the hot acid phenol method with glass bead
disruption [121].
For Northern Blot analysis, twenty micrograms of total RNA was resolved by
electrophoresis using a 1% agarose/1X MOPS gel with formaldehyde. The RNA was then
transferred to a nylon membrane and was probed using gene-specific probes that were
radioactively labeled at the 5’end with [ɣ-32P] ATP via the action of Polynucleotide kinase
(Roche, Manheim Germany). Probes were purified using Roche Quick Spin columns and
quantified using a scintillation counter. Blots were incubated in prehybridization solution
containing 6X SSC, 10X Denhardt’s solution and 0.1% SDS for 1 h at 42°C followed by
overnight hybridization with the 5’end labeled probe. Images were processed using a Storm
PhosphorImager and exposed to film for autoradiography. Ribosomal RNA (rRNA) visualized by
ethidium bromide staining was used as a loading control.
GFP reporter assays and fluorescence microscopy
Reporter strains were grown as described for Northern Blot analysis. After growing
reporter strains for 1 hr in YNB media plus one of three carbon sources: glucose (2%),
potassium acetate (2%) or oleate (0.5% oleic acid, 1% Tween 20), C. albicans cells were
harvested and visualized using an Olympus IX81–ZDC confocal inverted microscope (Tokyo,
Japan). All images were obtained using a 60X immersion oil objective, as well as the following
filters and exposure times: DIC (100 ms), FITC for GFP (100 ms) or TRITC for mCherry (500
ms). Subsequently, SlideBook 5.0 digital microscopy software (Intelligent Imaging Innovations,
Inc., Denver, CO, USA) was used to process DIC, FITC, and TRITC images. Quantification of
GFP fluorescence intensity was done essentially as described by Brothers et al., 2011 [122],
with some modifications. To quantify the level of fluorescence in individual cells on saved image
files, the SlideBook 5.0 circle tool was used to trace at least 50 cell segments (yeast, hyphae
and pseudohyphae), and a single area of background fluorescence. Each selected region was
converted to a mask object and the mask statistic mean function was then used to generate the
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mean FITC (green) and TRITC (red) fluorescence intensity values. After subtracting the
background value, the data were graphed using Excel as the mean green to red fluorescence
ratio ± S.D.
5’- RNA Ligase Mediated Rapid Amplification of cDNA Ends (5’-RLM-RACE) Analysis of
FOX2 and ICL1
To map transcription initiation sites within the FOX2 and ICL1 promoters, 5’ Rapid
amplification of complementary ends was performed using the FirstChoiceR RLM-RACE Kit
(Ambion, USA). RNA was extracted as described for Northern Blot analysis. Ten micrograms of
total RNA was treated with Calf Intestine Alkaline Phosphatase (CIP) and Tobacco Acid
Pyrophosphatase (TAP) to remove both free 5'-phosphates and the cap structure before the
ligation of a 5’-RLM-RACE adapter to the mRNA. The processed mRNA was then reverse
transcribed to cDNA, which served as the template for an outer PCR using a 5’-RLM-RACE
outer primer (Ambion) and a gene-specific outer primer. The outer PCR product was then
amplified by 5’-RLM-RACE inner primer (Ambion, USA) and a 5’ gene-specific inner primer. The
resulting PCR products were analyzed by agarose gel electrophoresis and sequencing.
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Table 2-1: Lists of C. albicans strains used for this study
Strain

Relevant genotype

SC5314
CAI4-F2

Wild-type prototroph
Wild-type auxotroph
(URA3-)
PromoterlessGFP/WT

AGC8

Complete genotype
ura3::λimm434/ura3:: λimm434

Source/
Reference
[112]
[112]

ura3::λimm434/ura3:: λimm434
his1::hisG/his1::hisG
RPS10/rps10:: GFP-URA3-HIS1

This study

AGC10

ACT1p-GFP/WT

ura3::λimm434/ura3:: λimm434
his1::hisG/his1::hisG
RPS10/rps10:: ACT1p-GFP-URA3-HIS1

This study

AGC22

FOX2p(1000)-GFP

ura3::λimm434/ura3:: λimm434
his1::hisG/his1::hisG
RPS10/rps10:: FOX2p(1000)-GFPURA3-HIS1

This study

AGC24

FOX2p(500)-GFP

ura3::λimm434/ura3:: λimm434
his1::hisG/his1::hisG
RPS10/rps10:: FOX2p(500)-GFP-URA3HIS1

This study

AGC26

FOX2p(400)-GFP

ura3::λimm434/ura3:: λimm434
his1::hisG/his1::hisG
RPS10/rps10:: FOX2p(400)-GFP-URA3HIS1

This study

AGC28

FOX2p(300)-GFP

ura3::λimm434/ura3:: λimm434
his1::hisG/his1::hisG
RPS10/rps10:: FOX2p(300)-GFP-URA3HIS1

This study

AGC30

FOX2p(200)-GFP

ura3::λimm434/ura3:: λimm434
his1::hisG/his1::hisG
RPS10/rps10:: FOX2p(200)-GFP-URA3HIS1

This study

AGC32

FOX2p(100)-GFP

ura3::λimm434/ura3:: λimm434
his1::hisG/his1::hisG
RPS10/rps10:: FOX2p(100)-GFP-URA3HIS1

This study

MLC61

ICL1p(1000)-GFP

ura3::λimm434/ura3:: λimm434
his1::hisG/his1::hisG
RPS10/rps10:: ICL1p(1000)-GFP-URA3HIS1

This study
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AGC12

ICL1p(500)-GFP

ura3::λimm434/ura3:: λimm434
his1::hisG/his1::hisG
RPS10/rps10:: ICL1p(500)-GFP-URA3HIS1

AGC14

ICL1p(400)-GFP

ura3::λimm434/ura3:: λimm434
his1::hisG/his1::hisG
RPS10/rps10:: ICL1p(400)-GFP-URA3HIS1

AGC16

ICL1p(300)-GFP

ura3::λimm434/ura3:: λimm434
his1::hisG/his1::hisG
RPS10/rps10:: ICL1p(300)-GFP-URA3HIS1

AGC18

ICL1p(200)-GFP

ura3::λimm434/ura3:: λimm434
his1::hisG/his1::hisG
RPS10/rps10:: ICL1p(200)-GFP-URA3HIS1

AGC20

ICL1p(100)-GFP

ura3::λimm434/ura3:: λimm434
his1::hisG/his1::hisG
RPS10/rps10:: ICL1p(100)-GFP-URA3HIS1

AGC96

Promoterless-GFP,
ADH1p-mCherry

ura3::λimm434/ura3:: λimm434
his1::hisG/his1::hisG
RPS10/rps10:: GFP-URA3-HIS1
ADH1/adh1::yCherry-SAT1

This study

AGC97

ACT1p-GFP,
ADH1p-mCherry

ura3::λimm434/ura3:: λimm434
his1::hisG/his1::hisG
RPS10/rps10:: ACT1p-GFP-URA3-HIS1
ADH1/adh1:: yCherry-SAT1

This study

AGC98

FOX2p(1000)GFP/ctf1Δ/Δ,
ADH1p-mCherry

ura3::λimm434/ura3:: λimm434
his1::hisG/his1::hisG
ctf1::HIS1/ctf1::hisG
RPS10/rps10:: FOX2p(1000)-GFPURA3-HIS1
ADH1/adh1:: yCherry-SAT1

This study

AGC99

ICL1p(1000)GFP/ctf1Δ/Δ,
ADH1p-mCherry

ura3::λimm434/ura3:: λimm434
his1::hisG/his1::hisG
ctf1::HIS1/ctf1::hisG
RPS10/rps10:: ICL1p(1000)-GFP-URA3HIS1
ADH1/adh1:: yCherry-SAT1

This study

AGC100

FOX2p(1000)-GFP,

ura3::λimm434/ura3:: λimm434

This study
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ADH1p-mCherry

his1::hisG/his1::hisG
RPS10/rps10:: FOX2p(1000)-GFPURA3-HIS1
ADH1/adh1:: yCherry-SAT1

AGC10

FOX2p(1000)-GFP,
ADH1p-mCherry

ura3::λimm434/ura3:: λimm434
his1::hisG/his1::hisG
RPS10/rps10:: FOX2p(1000)-GFPURA3-HIS1
ADH1/adh1:: yCherry-SAT1

This study

AGC102

FOX2p(500)-GFP,
ADH1p-mCherry

ura3::λimm434/ura3:: λimm434
his1::hisG/his1::hisG
RPS10/rps10:: FOX2p(500)-GFP-URA3HIS1
ADH1/adh1:: yCherry-SAT1

This study

AGC103

FOX2p(500)-GFP,
ADH1p-mCherry

ura3::λimm434/ura3:: λimm434
his1::hisG/his1::hisG
RPS10/rps10:: FOX2p(500)-GFP-URA3HIS1
ADH1/adh1:: yCherry-SAT1

This study

AGC104

FOX2p(400)-GFP,
ADH1p-mCherry

ura3::λimm434/ura3:: λimm434
his1::hisG/his1::hisG
RPS10/rps10:: FOX2p(400)-GFP-URA3HIS1
ADH1/adh1:: yCherry-SAT1

This study

AGC105

FOX2p(400)-GFP,
ADH1p-mCherry

ura3::λimm434/ura3:: λimm434
his1::hisG/his1::hisG
RPS10/rps10:: FOX2p(400)-GFP-URA3HIS1
ADH1/adh1:: yCherry-SAT1

This study

AGC106

FOX2p(300)-GFP,
ADH1p-mCherry

ura3::λimm434/ura3:: λimm434
his1::hisG/his1::hisG
RPS10/rps10:: FOX2p(300)-GFP-URA3HIS1
ADH1/adh1:: yCherry-SAT1

This study

AGC107

FOX2p(300)-GFP,
ADH1p-mCherry

ura3::λimm434/ura3:: λimm434
his1::hisG/his1::hisG
RPS10/rps10:: FOX2p(300)-GFP-URA3HIS1
ADH1/adh1:: yCherry-SAT1

This study

AGC108

FOX2p(200)-GFP,
ADH1p-mCherry

ura3::λimm434/ura3:: λimm434
his1::hisG/his1::hisG
RPS10/rps10:: FOX2p(200)-GFP-URA3-

This study
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HIS1
ADH1/adh1:: yCherry-SAT1
AGC109

FOX2p(200)-GFP,
ADH1p-mCherry

ura3::λimm434/ura3:: λimm434
his1::hisG/his1::hisG
RPS10/rps10:: FOX2p(200)-GFP-URA3HIS1
ADH1/adh1:: yCherry-SAT1

This study

AGC110

FOX2p(100)-GFP,
ADH1p-mCherry

ura3::λimm434/ura3:: λimm434
his1::hisG/his1::hisG
RPS10/rps10:: FOX2p(100)-GFP-URA3HIS1
ADH1/adh1:: yCherry-SAT1

This study

AGC111

FOX2p(100)-GFP,
ADH1p-mCherry

ura3::λimm434/ura3:: λimm434
his1::hisG/his1::hisG
RPS10/rps10:: FOX2p(100)-GFP-URA3HIS1
ADH1/adh1:: yCherry-SAT1

This study

AGC112

ICL1p(1000)-GFP,
ADH1p-mCherry

ura3::λimm434/ura3:: λimm434
his1::hisG/his1::hisG
RPS10/rps10:: ICL1p(1000)-GFP-URA3HIS1
ADH1/adh1:: yCherry-SAT1

This study

AGC113

ICL1p(500)-GFP,
ADH1p-mCherry

ura3::λimm434/ura3:: λimm434
his1::hisG/his1::hisG
RPS10/rps10:: ICL1p(500)-GFP-URA3HIS1
ADH1/adh1:: yCherry-SAT1

This study

AGC114

ICL1p(500)-GFP,
ADH1p-mCherry

ura3::λimm434/ura3:: λimm434
his1::hisG/his1::hisG
RPS10/rps10:: ICL1p(500)-GFP-URA3HIS1
ADH1/adh1:: yCherry-SAT1

This study

AGC115

ICL1p(400)-GFP,
ADH1p-mCherry

ura3::λimm434/ura3:: λimm434
his1::hisG/his1::hisG
RPS10/rps10:: ICL1p(400)-GFP-URA3HIS1
ADH1/adh1:: yCherry-SAT1

This study

AGC116

ICL1p(400)-GFP,
ADH1p-mCherry

ura3::λimm434/ura3:: λimm434
his1::hisG/his1::hisG
RPS10/rps10:: ICL1p(400)-GFP-URA3HIS1
ADH1/adh1:: yCherry-SAT1

This study
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AGC117

ICL1p(300)-GFP,
ADH1p-mCherry

ura3::λimm434/ura3:: λimm434
his1::hisG/his1::hisG
RPS10/rps10:: ICL1p(300)-GFP-URA3HIS1
ADH1/adh1:: yCherry-SAT1

This study

AGC118

ICL1p(300)-GFP,
ADH1p-mCherry

ura3::λimm434/ura3:: λimm434
his1::hisG/his1::hisG
RPS10/rps10:: ICL1p(300)-GFP-URA3HIS1
ADH1/adh1:: yCherry-SAT1

This study

AGC119

ICL1p(200)-GFP,
ADH1p-mCherry

ura3::λimm434/ura3:: λimm434
his1::hisG/his1::hisG
RPS10/rps10:: ICL1p(200)-GFP-URA3HIS1
ADH1/adh1:: yCherry-SAT1

This study

AGC120

ICL1p(200)-GFP,
ADH1p-mCherry

ura3::λimm434/ura3:: λimm434
his1::hisG/his1::hisG
RPS10/rps10:: ICL1p(200)-GFP-URA3HIS1
ADH1/adh1:: yCherry-SAT1

This study

AGC121

ICL1p(100)-GFP,
ADH1p-mCherry

ura3::λimm434/ura3:: λimm434
his1::hisG/his1::hisG
RPS10/rps10:: ICL1p(100)-GFP-URA3HIS1
ADH1/adh1:: yCherry-SAT1

This study
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Table 2-2: Lists of plasmids used for this study
Plasmid

Description

Source/
Reference
[117]

pGFP

Promoterless GFP in CIp10, URA3 selection marker,
ampicillin resistance

pADH1mCherry

Construct to integrate mCherry at the ADH1 locus,
driven by the ADH1 promoter. Nourseothricin selection
marker

[122]

pAG3-1

ICL1p(1000)-pGFP

This study

pAG4-1

ICL1p(500)-pGFP

This study

pAG5-1

ICL1p(400)-pGFP

This study

pAG6-1

ICL1p(300)-pGFP

This study

pAG7-1

ICL1p(200)-pGFP

This study

pAG8-1

ICL1p(100)-pGFP

This study

pAG9-1

FOX2p(1000)-pGFP

This study

pAG10-1 FOX2p(500)-pGFP

This study

pAG11-1 FOX2p(400)-pGFP

This study

pAG12-1 FOX2p(300)-pGFP

This study

pAG13-1 FOX2p(200)-pGFP

This study

pAG14-1 FOX2p(100)-pGFP

This study
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Table 2-3: List of oligonucleotides used for this study
Gene Oligonucleotide
name (oligo)

Description

Sequencea

MLO1128

Promoter deletion analysis
5’ oligo -1000 bp
CCAGGTACCAATCAACAATTTGAGGTT
relative to ATG
TGT
5’ oligo -500 bp
CCAGGTACCTTGCTGTTGGCATTGTG
TAATAAT
5’ oligo -400 bp
CCAGGTACCTCGTTGTGTTATGTTAAA
GTGGAA
5’ oligo -300 bp
CCAGGTACCTAATACACACGACTTTTC
TCCAG
5’ oligo -200 bp
CCAGGTACCACAACAAATGATATGAAT
GAATATTTA
5’ oligo -100 bp
CCAGGTACCCATCTGAAATTTATTTAA
TTGAAA
3’ oligo -1 bp
AGTAAGCTTGGAGGAAAGTATTATGTT
TGA
5’ oligo for
GGAATTCCCACTTTTTATTTCATCTTG
deletion of
GTTGAAGATG
CCTCGG
Reverse
CATCTTCAACCAAGATGAAATAAAAAG
complement of
TGGGAATTCC
MLO1125
5’ oligo for siteGAATTCCCACTTTTTATTTCATCCATCA
directed
GTTGGTTG
mutagenesis of
CCTCGG motif
(CATCAG)
Reverse
CAACCAACTGATGGATGAAATAAAAAG
complement of
TGGGAATTC
MLO1127

ICL1

MLO888

5’ oligo -1000 bp

ICL1

MLO889

ICL1

MLO890

ICL1

MLO891

ICL1

MLO892

ICL1

MLO893

ICL1

MLO1015

FOX2 MLO882
FOX2 MLO883
FOX2 MLO884
FOX2 MLO885
FOX2 MLO886
FOX2 MLO887
FOX2 MLO1022
FOX2
MLO1125
FOX2
MLO1126
FOX2

MLO1127
FOX2

FOX2 MLO329

CCAGGTACCCCAGCGTGGTCATGGAA
TCGT
5’ oligo -500 bp
CCAGGTACCGTCAGCTTTTCTACTCAA
TCC
5’ oligo -400 bp
CCAGGTACCGAATCAAAATAGATGTAA
TGTGATG
5’ oligo -300 bp
CCAGGTACCGGATCAGTGGAAGATTG
CGAG
5’ oligo -200 bp
CCAGGTACCGTCCGATTACAATATTTG
GCCC
5’ oligo -100 bp
CCAGGTACCAAATTTCATTCTTTTTTAA
TACCC
3’ oligo -1 bp
AGTAAGCTTGGTAGATATTATTAATGT
TTATTCTT
Northern Blot Analysis
3’ oligo +1700 bp ACAGTGGTGTGTTCATCGTG
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3’ oligo +2153 bp TAAGCCTTGGCTTTGGATTCT
3’ oligo +536 bp
TACCAGCAGCAGTAACAAATTCT
5’RACE Analysis
FOX2 MLO1261
Gene specific
GTTGTTGTCAACGATTTAGGAGGT
oligo +103 bp
FOX2 MLO1262
Gene specific
ACCACCGTTCTTGGTAATTTCA
inner oligo +197
bp
FOX2 MLO1263
Gene specific
TCAACAATTTTGGCACCATCCA
outer oligo +247
bp
ICL1 MLO1264
Gene specific
GGTCTGAACCAAGATGGAGAAA
oligo +77 bp
ICL1 MLO1265
Gene specific
AACAGTCTTGTCAGCATCGTGT
inner oligo +228
bp
ICL1 MLO1266
Gene specific
AGTACTTGGCCATTTGAGCAACGT
outer oligo +283
bp
a
The restriction sites introduced into the primers are underlined;
KpnI (GGTACC ), HindIII (AAGCTT)
ICL1
GFP

MLO66
MLO1094
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Chapter 3. Identification of cis-acting elements in the promoters of CTF1 co-regulated
genes, FOX2 and ICL1
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Introduction
Increasing evidence indicates the ability to use a wide variety of gluconeogenic
substrates may be an important aspect of C. albicans pathogenicity. As mentioned previously,
C. albicans undergoes a dramatic reprogramming of transcription in order to adapt to changing
host microenvironments. Elucidating transcriptional regulatory networks that govern alternative
carbon metabolism is important in order to gain insight into C. albicans pathogenic
characteristics. However, there is a gap in knowledge of how C. albicans controls the
expression of carbon metabolic genes. Much of what we know about the transcriptional
regulatory networks governing alternative carbon metabolic pathways is based on the
paradigms seen in S. cerevisiae and A. nidulans. Several studies have revealed significant
differences between C. albicans and S. cerevisiae, and increasing evidence shows these
processes are more analogous to those employed by A. nidulans. For example, in A. nidulans
and C. albicans, β-oxidation and peroxisome biogenesis are regulated by the orthologues
FarA/FarB and CTF1, but the unrelated transcription factors Oaf1/Pip2 in yeast [83,93,105].
Work published by our laboratory [75,83], showed a ctf1Δ/Δ mutant strain in a mouse model of
disseminated candidiasis showed a mild, but significant attenuation in virulence. The results
were comparable to a fox2∆/∆ mutant which showed a mean time to death of 6.9 days,
compared to 4.8 days for the wild-type strain [75,83]. Because CTF1 is also relevant in vivo, it is
important to gain insight on how CTF1 regulates target genes (e.g. FOX2 and ICL1). Northern
blot analysis of strains grown in glucose and the non-fermentable carbon sources, acetate and
oleate was used to assess the endogenous expression of CTF1, FOX2 and ICL1 genes [83].
Several observations were made based on Northern blot analysis. First, the absence of CTF1
mRNA transcripts in the tested conditions other than oleate indicates CTF1 is regulated by
carbon source. Second, CTF1 positively regulates the expression of FOX2 and ICL1 only in the
presence of oleate [83]. Third, ICL1 is expressed in a CTF1-independent manner in the
presence of acetate, suggesting additional transcription factor(s) must be involved [83]. Recent
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microarray analysis derived from wild-type vs. ctf1Δ/Δ mutant strains grown in glucose or oleate
revealed a large CTF1-dependent regulon (217 genes) [Ramírez, MA and Lorenz, MC
unpublished data]. The results show CTF1 regulates genes required for fatty acid catabolism,
gluconeogenesis, and the glyoxylate cycle, as well as glucose transport and a few genes
involved in other cellular processes. Surprisingly, 60% of the genes in this regulon lack
homology to those found in other organisms or their homologs have not been characterized. C.
albicans is highly specialized to exist within its host as a commensal, and when given the
opportunity (e.g. defects in host immunity) it can alter its transcriptional response to adapt to
changing host microenvironments, causing disease. Although CTF1 itself has a partial
contribution to C. albicans virulence, CTF1-dependent genes that are transcriptionally
upregulated in response to fatty acids and are fungal specific may represent genes that are
important for C. albicans pathogenicity making them potential candidates for development of
antifungal drugs. Genetic data indicate FOX2 and ICL1 are regulated by carbon source and that
CTF1 plays a major role in the regulation of these genes. Previous studies clearly highlight the
importance of CTF1 as a regulator of fatty acid degradation, yet there is limited knowledge on
how CTF1 regulates its targets. Of the CTF1 regulon I have focused on FOX2 and ICL1 in this
study as model targets. The analysis of FOX2 and ICL1 promoter regions will help understand
the mechanism of regulation by CTF1 of target genes, including whether regulation is direct or
indirect. The knowledge resulting from understanding the mechanisms that govern gene
expression of key metabolic enzymes can be used for designing novel antifungal drugs.
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Results
Endogenous FOX2 and ICL1 are rapidly expressed in alternative carbon sources
The expression pattern of FOX2 and ICL1 from a wild-type background was determined
over a three-hour period following transfer to media containing glucose, acetate or oleate as the
sole carbon source (Figure 3-1 and 3-2). As demonstrated previously by our lab [75,83],
Northern blot analysis probing for the endogenous FOX2 and ICL1 genes show their expression
is completely repressed in the presence of glucose. Transcripts for both FOX2 and ICL1 genes
were detected within 30 minutes of incubation in the presence of acetate and oleate indicating a
rapid cellular response to changing carbon conditions. Interestingly, high FOX2 expression
levels are maintained throughout the three hours in oleate, but an apparent decline is seen after
two hours in acetate. Based on these data, full induction of these genes should be observed
within one hour. Therefore, a one hour timepoint was chosen for later experiments.
Identification of cis-acting elements involved in the regulation of FOX2 and ICL1 genes
The expression pattern of a gene is in great part determined by cis-acting elements or
motifs that are binding sites for specific transcription factors. Hence, the analysis of promoter
regions to identifying regulatory motifs is important to understand regulation of specific genes.
To identify cis-acting sequences important for the regulation of FOX2 and ICL1, a combination
of bioinformatic analysis and promoter deletion analysis was employed. Initially to dissect FOX2
and ICL1 promoters, we used the LacZ reporter system. However, inconsistent results were
obtained upon analyzing β-galactosidase activity. Instead, we choose to use GFP as a reporter
of transcription. The GFP reporter is a good alternative to enzymatic reporters. For example,
the GFP fluorescence signal from a single cell or a population of cells can be analyzed via
fluorescence microscopy without the need to disrupt cells [123]. The GFP reporter system was
constructed as described in Chapter 2 and as shown in figure 3-3. Briefly, constructs consisting
of 1000 bp 5’ of the translational start of both genes were cloned upstream of the GFP ORF. I
also made 5’ sequential deletions at 100 bp intervals upstream of the translational start codon of
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each gene to isolate promoter fragments with relevant cis-acting sequences. To make C.
albicans GFP reporter strains, constructs were used to transform a wild-type strain (CAI4-F2) or
ctf1Δ/Δ mutant strain (MRC39). Integration at the desired RPS10 locus was confirmed by PCR.
Reporter strains were grown as described in Figure 3-1, and cells were subsequently washed
and analyzed by fluorescence microscopy. Initial attempts to quantify expression were
complicated by inter-experimental variability, compromising interpretation of the data. Therefore,
a different approach described by Brothers et al., 2011 [122] was used to quantify GFP
fluorescence intensity. This new approach requires the introduction of an additional expression
plasmid encoding the red fluorescent protein (ADH1-mCherry) at the ADH1 locus. The
constitutive mCherry expression serves as an internal fluorescence standard.
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Figure 3-1. Diagram for growth of strain in glucose or non-fermentable carbon sources
The wild-type (SC5314) strain was grown overnight in YPD, collected by centrifugation, washed
with water and diluted in YNB supplemented with 2% glucose and grown to log-phase. Cells
were collected by centrifugation, washed and grown in YNB with 2% glucose, 2% potassium
acetate or 0.5% oleic acid/1% tween 20 for 1 hr at 30C. RNA was extracted for Northern Blot
analysis as described in chapter 2.
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Figure 3-1. Diagram for growth of strain in glucose or non-fermentable carbon sources
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Figure 3-2. FOX2 and ICL1 expression is rapidly induced by alternative carbon sources
The wild-type (SC5314) strain was grown overnight in YPD, collected by centrifugation, washed
with water and diluted in YNB supplemented with 2% glucose and grown to log-phase. Cells
were collected by centrifugation, washed and incubated at 30C for a three-hour period in YNB
media containing 2% glucose, 2% potassium acetate or 0.5% oleic acid/1% tween 20.
Endogenous FOX2 A) and ICL1 B) gene expression was detected via Northern blot analysis
using gene-specific probes. Ethidium bromide staining of the rRNA was used as a loading
control.
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Figure 3-2. FOX2 and ICL1 expression is rapidly induced by alternative carbon sources
A)
GLUCOSE

ACETATE

OLEATE

ACETATE

OLEATE

B)
GLUCOSE
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Figure 3-3. Schematic representation of reporter strains used for promoter deletion
analysis
1000 bp 5’ of the translational start and systematic 100 bp deletions of the FOX2 or ICL1
promoters were fused to GFP and chromosomally integrated into a wild-type strain (CAI4-F2) or
ctf1Δ/Δ mutant strain (MRC39) at the phenotypically neutral RPS10 locus. The constitutive
mCherry expression of the reporter strains serves as an internal reference. At least two
independent strains were tested.
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Figure 3-3. Schematic representation of reporter strains used for promoter deletion
analysis
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CTF1 regulates the FOX2 and ICL1 promoters in non-fermentable carbon sources
The GFP reporter system has been employed in this study to gain insight into how CTF1
regulates its targets, FOX2 and ICL1. The expression of 1000 bp FOX2-GFP and ICL1-GFP
reporter strains, as well as the appropriate control strains was assessed using fluorescence
microscopy as described in Chapter 2. The representative images are shown in figure 3-4.
Because all the strains exhibit constitutive mCherry expression, the ratio of GFP to mCherry
fluorescence was generated to effectively normalize the GFP fluorescence intensity throughout
the different reporter strains and conditions tested (Figure 3-5). Overall, GFP reporter results in
a wild-type background correspond to previous Northern blot data obtained by our lab [83].
Fluorescence microscopy analysis of control strains shows that regardless of the conditions
tested, high GFP fluorescence intensity is detected in the positive, but not the negative control
strain. Consistent with FOX2 and ICL1 being glucose-repressed, expression of these genes was
not detected in glucose-containing media. On the other hand, FOX2-GFP and ICL1-GFP
reporter strains were fluorescent in media containing acetate or oleate, indicating carbon-source
dependent expression. These results are consistent with previous Northern analysis.
To determine the contribution of CTF1 in regulating FOX2 and ICL1, I analyzed the 1000
bp FOX2-GFP and ICL1-GFP reporters in a ctf1Δ/Δ mutant background (MRC39). In the
absence of CTF1, the FOX2 reporter still shows some GFP activity in the presence of acetate
and oleate that is apparent in the Northern Blot data and upon quantification of GFP
fluorescence. This indicates that in the absence of CTF1, FOX2 is no longer induced, but it is
still subject to derepression. In contrast, minimal GFP activity is seen for the ICL1 reporter in the
same conditions suggesting CTF1 is required for ICL1 expression even in the presence of
acetate. As mentioned previously, Northern blot data generated by Ramirez and Lorenz, 2009
[83] showed CTF1 is not required for the expression of ICL1 in acetate. The current ICL1
reporter data in a ctf1Δ/Δ mutant background contradicts their data. This discrepancy may be
as a result of variations in the strains and requires further analysis.
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Figure 3-4. CTF1 regulates the FOX2 and ICL1 promoters in non-fermentable carbon
sources
Fluorescence microscopy analysis of empty-GFP/WT (A) and ACT1-GFP/WT (B). Fluorescence
microscopy analysis of FOX2-GFP/WT (C), FOX2-GFP/ctf1Δ/Δ (D), and ICL1-GFP/WT (E),
ICL1-GFP/ctf1Δ/Δ (F). C. albicans wild-type cells expressing GFP reporters at the RPS10 locus,
as well as ADH1-mCherry at the ADH1 locus were harvested and visualized using an Olympus
IX81–ZDC confocal inverted microscope (Tokyo, Japan). All images were obtained using a 60X
immersion oil objective and the following channels and exposure times: DIC (100 ms), FITC for
GFP (100 ms) or TRITC for mCherry (500 ms). SlideBook 5.0 (Intelligent Imaging Innovations,
Inc., Denver, CO, USA) was used to analyze all images.
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Figure 3-4. CTF1 regulates the FOX2 and ICL1 promoters in non-fermentable carbon
sources
A)

pGFP/WT

GLUCOSE

ACETATE

OLEATE

B)

1000 ACT1 pGFP/WT

GLUCOSE

ACETATE

OLEATE

49

C)

1000 FOX2-pGFP/WT

GLUCOSE

ACETATE

OLEATE

D)

1000 FOX2-pGFP/ctf1Δ/Δ

GLUCOSE

ACETATE

OLEATE
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E)

1000 Icl1-pGFP/WT

GLUCOSE

ACETATE

OLEATE

F)

1000 ICL1-pGFP/ctf1Δ/Δ

GLUCOSE

ACETATE

OLEATE
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Figure 3-5. Quantification of GFP fluorescence intensity
To quantify GFP fluorescence intensity, the ellipse tool from SlideBook 5.0 was used to select at
least 50 cell segments (yeast, hyphae and pseudohyphae), and a single area of background
fluorescence [122]. Each selected region was converted to a mask object and the mask statistic
mean function was then used to generate the mean FITC (green) and TRITC (red) fluorescence
intensity values. After subtracting the background value, the data were graphed using Excel as
the mean green to red fluorescence ratio ± S.D.
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Figure 3-5. Quantification of GFP fluorescence intensity
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Several transcription initiation sites are located within the FOX2 and ICL1 promoters
To identify cis-acting sequences within the FOX2 and ICL1 promoters, the next step was
to perform promoter truncation analysis. Before proceeding, it was important to ensure that any
loss of GFP activity was not due to deletion of transcription initiation sites within proximal
promoter regions. Transcription initiation sites had not been previously mapped for FOX2 and
ICL1. Therefore, 5’- RNA Ligase Mediated Rapid Amplification of cDNA Ends (5’-RLM-RACE)
was used to determine transcription initiation sites within the FOX2 and ICL1 promoters. The 5’RLM-RACE PCR reactions for each promoter resulted in multiple bands. However, sequencing
of the PCR fragments revealed the location of the transcription initiation sites within the FOX2
and ICL1 promoters (Figure 3-6). The results showed that the FOX2 promoter contains two
transcription initiation sites at positions -100 and -74 relative to the translation start codon,
whereas the ICL1 promoter contains only one transcription initiation site located at position -95.
As expected, both the FOX2 and ICL1 promoters contain at least one TATA box consensus
sequence (TATAWAWR, W indicates A/T; R indicates A/G) [124] within a reasonable distance
upstream of the transcription initiation sites (Figure 3-6). The FOX2 promoter has two
overlapping putative TATA boxes between positions – 168 and -161, and -164 and -157. On the
other hand, only one TATA box can be found in the ICL1 promoter between positions – 140 and
-133. TATA-containing genes are known to be involved in response to environmental stress
such as heat and starvation [124]. The presence of putative TATA boxes within these
promoters agrees with the involvement of FOX2 and ICL1 in the assimilation of alternative
carbon sources.
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Figure 3-6. Several transcription initiation sites are located within the FOX2 and ICL1
promoters
To map transcription initiation sites within the FOX2 and ICL1 promoters, 5’RACE PCR analysis
was performed using both 5’RACE primers and gene-specific primers. Processed mRNA
harboring a 5’RACE adapter was reverse transcribed to cDNA and used as the PCR template.
The location of transcription initiation sites within the FOX2 and ICL1 promoters was then
revealed via agarose gel electrophoresis and sequencing analysis of the resulting 5’RACE PCR
products.
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Figure 3-6. Several transcription initiation sites are located within the FOX2 and ICL1
promoters
A)

B)
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Putative DNA binding sites within the FOX2 and ICL1 promoters
In parallel with promoter deletion analysis we began a search for putative DNA binding
sites within the FOX2 and ICL1 promoters that are regulated by carbon source through a survey
of the literature. Transcription factors with zinc binuclear clusters can recognize regulatory
elements that contain trinucleotide sequences (e.g CGG) in single or repeat forms, in either a
symmetrical or an asymmetrical format [125]. In addition to binding DNA as monomers, these
transcription factors can function as homodimers or as heterodimers [126]. DNA binding
specificity is largely determined by the orientation of trinucleotide sequences and the nucleotide
spacing between the triplets [127]. In the plant pathogen Fusarium solani, the CTF1 orthologue,
CTF1α binds a GC-rich palindrome with an oppositely oriented 5’-GCC(n2)GGC to induce the
cutinase gene in the presence of fatty acids [108]. In A. nidulans, both FarA and FarB positively
regulate genes involved in fatty acid catabolism by binding sequences containing the 6-bp core
CCTCGG motif [105]. According to Hynes et al., 2006, the CCTCGG motif is overrepresented
in the 5’ regions of genes predicted to be induced by fatty acids in filamentous fungi, but not in
S. cerevisiae [105].
Guided by the studies performed in other fungi including F. solani and A. nidulans we
decided to scan 1000 bp upstream of the translational start codon for exact matches to the
CCTCGG sequence using pattern match software (Patmatch) from the Candida genome
database (http://www.candidagenome.org/cgi-bin/PATMATCH/nph-patmatch). Patmatch
analysis revealed one or more copies of the CCTCGG motif are present in the promoters of
CTF1 target genes including FOX2 and ICL1 (Figure 3-7). A single copy of the CCTCGG motif
was found between -350 and -355 relative to the translational start codon in FOX2. On the
other hand, ICL1 contains two regions with the CCTCGG motif positioned between -618 and 623, and its complement, CCGAGG positioned between -333 and -338, respective to the
translational start codon. A more extensive Patmatch analysis showed the motif was also
conserved in numerous other C. albicans genes that have a known role in alternative carbon
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metabolism. A total of 252 genes containing the CCTCGG motif and its complement within
1,000 bp 5' of the translational start codon were analyzed by the Gene Ontology (GO) term
mapper from the Candida genome database (http://www.candidagenome.org/cgibin/GO/goTermMapper) (Table 3-1) [Lorenz, M. C., unpublished results). The GO term mapper
results for these genes show an overrepresentation of genes that are induced by fatty acids,
such as those involved in β-oxidation and peroxisome processes. For example, the fatty acid
oxidation GO term shows that the CCTCGG motif and its complement are upstream of 9 out of
12 genes annotated to that term (Table 3-1).
Transcript profiling studies performed by Murad et al., 2001 [107] identified both FOX2
and ICL1 as targets for MIG1 repression in C. albicans. Nehlin and Rohne, 1990 [87] previously
identified the sequence 5’-(G/C)(C/T)GG(G/A)G or SYGGRG as the DNA binding element for
Mig1 in S. cerevisiae. Because FOX2 and ICL1 are under glucose repression it is possible that
they harbor a Mig1 site that allows their expression to be repressed. To determine if FOX2 and
ICL1 harbor this putative Mig1 binding site, I scanned the promoters using Patmatch and found
both promoters carry multiple copies within 1000 bp upstream of the translational start codon.
Putative Mig1 sites were found within the following regions: -865 to -860, -623 to -618, -282 to
-277, and -260 to -255 for the FOX2 promoter, whereas ICL1 harbored two putative sites within
-747 to -742 and-252 to -247 regions (Figure 3-7). The relevance of the putative DNA binding
sites found by bioinformatic analysis in C. albicans needs to be assessed in future studies.
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Figure 3-7. Putative DNA binding sites within the FOX2 and ICL1 promoters
Pattern match software (Patmatch) from the Candida genome database was used to find
putative DNA binding sequences within the FOX2 A) and ICL1 B) promoters. Putative DNA
binding sequences include the fatty acid response element, CCTCGG
degenerate SYGGRG sequence

, as well as the more

required for Mig1 repression.
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Figure 3-7. Putative DNA binding sites within the FOX2 and ICL1 promoters
A)

B)
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Table 3-1. GO-enriched terms for genes with CCGAGG/CCTCGG within 1,000 bp 5' of the
translational start codon
Process
GO terms

Cluster
Frequency
(252
genes)

Background
Frequency
(6514
genes)

Corrected False
P-value
Discovery
Rate

fatty acid
oxidation

9, 3.6%

12, 0.2%

1.60E-08

0.00%

lipid oxidation

9, 3.6%

12, 0.2%

1.60E-08

0.00%

fatty acid βoxidation

8, 3.2%

10, 0.2%

9.03E-08

0.00%

lipid
modification

10, 4.0%

30, 0.5%

4.55E-05

0.00%

cellular lipid
catabolic
process

9, 3.6%

28, 0.4%

0.00029

0.00%

fatty acid
metabolic
process

12, 4.8%

58, 0.9%

0.00075

0.00%

monocarboxylic
acid
metabolism

14, 5.6%

89, 1.4%

0.00319

0.00%

lipid catabolic
process

9, 3.6%

40, 0.6%

0.00766

0.00%

Gene(s)
annotated
to the term
PEX11:FOX2:
POX1-3:PXP2:
orf19.4122:
CAT2:PEX5:
POX1:ANT1
PEX11:FOX2:
POX1-3:PXP2:
orf19.4122:
CAT2:PEX5:
POX1:ANT1
FOX2:POX1-3:
PXP2:orf19.41
22:CAT2:PEX5
:POX1:ANT1
PEX11:FOX2:
POX1-3:PXP2:
orf19.4122:
CAT2:orf19.48
65:PEX5:
POX1:ANT1
FOX2:POX1-3:
PXP2:orf19.41
22:CAT2:PEX5
:POX1:ANT1:
PLB3
PEX11:FOX2:
POX1-3:PXP2:
CRC1:orf19.41
22:CAT2:PEX5
:POX1:ANT1:
PEX13:PEX7
PEX11:FOX2:
POX1-3:PXP2:
CRC1:orf19.41
22:CAT2:MLS1
:PEX5:POX1:
ANT1:ICL1:
PEX13:PEX7
FOX2:POX1-3:
PXP2:orf19.41
22:CAT2:PEX5
:POX1:ANT1:
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hydrogen
peroxide
catabolism
glyoxylate
cycle

3, 1.2%

3, 0.0%

0.02712

1.09%

3, 1.2%

3, 0.0%

0.02712

1.00%

glucose
transport

6, 2.4%

22, 0.3%

0.06644

1.14%

peroxisomal
transport

5, 2.0%

15, 0.2%

0.08637

1.20%

5, 2.0%

15, 0.2%

0.08637

1.12%

protein
targeting to
peroxisome
Component
GO_terms

peroxisome

17, 6.7%

48, 0.7%

9.91E-11

0.00%

peroxisomal
part

7, 2.8%

22, 0.3%

0.00147

0.00%

PLB3
CAT1:TSA1B:
TSA1
FOX2:MLS1:
ICL1
HGT6:SHA3:
HGT17:HGT19
HGT10:HGT13
PEX4:PEX5:
PEX1:PEX13:
PEX7
PEX4:PEX5:
PEX1:PEX13:
PEX7

PEX11:orf19.1
64:POX13:PX
P2:PEX4:orf19
.4122:CAT2:
MLS1:PEX5:
POX1:CAT1:
ANT1:PEX1:
orf19.6591:
ICL1:PEX13:
PEX7
PEX11:orf19.1
64:POX1-3:
PEX5:CAT1:
ANT1:PEX13
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The CCTCGG motif is required for FOX2 regulation
To identify promoter regions that harbor relevant cis-acting sequences, I tested the 5’
sequential deletions at 100 bp intervals upstream of the start codon of each gene and analyzed
them in a wild-type background using Northern Blot and Fluorescence microscopy. Northern
Blot analysis of the 100 bp-FOX2 deletions showed that in contrast to the 1000 and 500 bpFOX2-GFP promoter fragments, there is a significant reduction in expression for the 400 bp and
300 bp fragments (Figure 3-8 A). These results indicated that the region between -500 and -300
is important for fatty acid regulation. However, fluorescence microscopy analysis demonstrated
that cis-acting sequences under positive fatty acid regulation are more likely to be located
between -400 and -300 (Figure 3-8 B). Based on these results and the fact that the CCTCGG
motif is found at position -350 within the FOX2 promoter, I hypothesized that this motif is the
relevant cis-acting sequence under positive fatty acid regulation. To test this, I made additional
reporter constructs that consisted of 1000 bp upstream of the start codon with either a deleted
motif or a motif with a specific-site mutation (CCTCGG  CCTCAG). The relevance of the
CCTCGG motif was analyzed using fluorescence microscopy (Figure 3-9). The results show a
significant reduction in GFP fluorescence upon deleting the CCTCGG motif. A disadvantage of
deleting the motif is that a new sequence is generated and it is often necessary to perform sitespecific mutations to maintain intact flanking sequences. Changing a guanine to an adenine
residue in the CGG triplet showed a reduced GFP activity indicating that the second guanine
residue is important for positive fatty acid regulation. Surprisingly, a reduction in GFP
expression is seen in acetate. It is possible that changing the guanine residue may lead to a
change in DNA conformation that allows a subtle Mig1-dependent or –independent repression.
Overall, these results are consistent with other studies performed in related fungi were the
importance of the CCTCGG motif for carbon source regulation has been shown. In particular,
the second guanine residue in the CGG triplet was determined to be the dominant contact for
Gal4 binding in S. cerevisiae [128], suggesting that a similar scenario may occur in C. albicans.
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Figure 3-8. FOX2 promoter contains one cis-acting element under fatty acid regulation
A) The wild-type (SC5314) strain and FOX2-GFP reporter strains harboring 5’ 1000 bp or
systematic 100 bp deletions (see table 2-1) were grown overnight in YPD, collected by
centrifugation, washed with water and diluted in YNB supplemented with 2% glucose and grown
to log-phase. Cells were collected by centrifugation, washed and incubated at 30C for a onehour period in YNB media containing 2% glucose, 2% potassium acetate or 0.5% oleic acid/1%
tween 20. Expression of endogenous FOX2 gene and the GFP gene was detected via Northern
blot analysis using gene-specific probes. Ethidium bromide staining of the rRNA was used as a
loading control. B) Quantification of FOX2-GFP reporter strains was performed as described
previously chapter 2.
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Figure 3-8. FOX2 promoter contains at least one cis-acting element under fatty acid
regulation

A)

FOX2-pGFP/WT

B)
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Figure 3-9. The CCTCGG motif is required for FOX2 regulation

Overlap extension PCR was used to delete the entire CCTCGG motif from the FOX2 promoter
or to mutate key residues using site-directed mutagenesis (SM) (CCTCGG  CCTCAG).
FOX2-GFP reporter strains lacking the CCTCGG motif or containing the mutagenized version
(see table 2-1) were grown overnight in YPD, collected by centrifugation, washed with water and
diluted in YNB supplemented with 2% glucose and grown to log-phase. Cells were collected by
centrifugation, washed and incubated at 30C for a one-hour period in YNB media containing
2% glucose, 2% potassium acetate or 0.5% oleic acid/1% tween 20. Quantification of reporter
strains was performed as described previously.
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Figure 3-9. The CCTCGG motif is required for FOX2 regulation
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The CCTCGG motif does not appear to be relevant for ICL1 regulation, whereas
additional unidentified elements seem to be important
The 5’ sequential deletions at 100 bp intervals upstream of the start codon of ICL1 were
also analyzed in a wild-type background using Northern Blot and Fluorescence microscopy.
Northern Blot analysis of the 100 bp-ICL1 deletions showed the ICL1 promoter contains one or
more positively regulated sites between -1000 and -500 relative to the translational start (Figure
3-10). As shown previously in figure 3-7, the ICL1 reporter harbors a CCTCGG motif between 623 to -618 and its complement between -338 to -333 relative to the translational start codon.
Therefore, I hypothesized that the CCTCGG motif found between -623 to -618 in the ICL1
promoter was a relevant cis-acting sequence for ICL1 regulation. Overlap extension PCR was
used to delete or mutagenize this motif using the 1000 bp-GFP reporter construct as a template.
The goal was to delete or alter each motif as done previously for FOX2. Initial PCR products
were obtained and used as templates to create a final PCR product. However, even after
multiple attempts I was unable to generate a final PCR product. As a result, the relevance of the
CCTCGG motif for ICL1 regulation could not be assessed. Therefore, I decided to create
additional 5’ systematic deletions at 100 bp intervals between the -1000 and -500 promoter
region relative to the translational start. Quantification of GFP fluorescence of the ICL1 reporter
in a wild-type background suggests ICL1 contains one or more positively regulated sites
between -1000 and -900 relative to the translational start codon. Overall, these results suggest
that it is unlikely that the CCTCGG motifs found at positions -618 and the complement,
CCGAGG at position -333 are relevant for ICL1 regulation. Conclusions and a discussion of
these findings are addressed in the next chapter.
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Figure 3-10. ICL1 cis-acting elements are found upstream of -900 position and CCTCGG
motif does not appear to be relevant for ICL1 regulation.
A) The ICL1-GFP reporter strains harboring 5’ 1000 bp or systematic 100 bp deletions (see
table 2-1) were grown overnight in YPD, collected by centrifugation, washed with water and
diluted in YNB supplemented with 2% glucose and grown to log-phase. Cells were collected by
centrifugation, washed and incubated at 30C for a one-hour period in YNB media containing
2% glucose, 2% potassium acetate or 0.5% oleic acid/1% tween 20. Expression of ICL1-GFP
was detected via Northern blot analysis using a GFP-specific probe. Ethidium bromide staining
of the rRNA was used as a loading control. B) Quantification of ICL1-GFP reporter strains was
performed as described previously.
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Figure 3-10. ICL1 cis-acting elements are found upstream of -900 position and CCTCGG
motif does not appear to be relevant for ICL1 regulation.

A)

ICL1p-pGFP/WT

B)
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Chapter 4. Conclusions and Perspectives
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In the past two decades, there has been an increase in infections caused by
opportunistic fungal pathogens. The rise of hospital-acquired fungal infections has been
attributed in part to an increase in immunocompromised and non-immunocompromised,
critically ill patients. In addition, the management of invasive candidiasis is complicated by
several factors including poor diagnosis, inadequate or delayed treatment, drug-related toxicity
and increasing drug resistance. Under predisposing conditions, C. albicans can switch from a
commensal to a pathogenic state, causing a broad range of infections which manifest as
superficial or systemic infections. Because C. albicans is considered the predominant cause of
invasive candidiasis and is associated with high morbidity and mortality, it has become the
subject of extensive research. However, most studies have focused on classical virulence
factors such as adhesins and hydrolytic enzymes involved in persistence of colonization. Less
emphasis has been placed on the metabolic requirements of C. albicans during infection.
C. albicans has the ability to survive in a variety of harsh micro-environments within its
mammalian host. Its remarkable plasticity in adapting to diverse host niches is reflected by its
ability to invade virtually any site of the human body. The nutrient composition in different
anatomical sites varies throughout the body, and some micro-environments lack preferred
carbon sources that allow fungal growth and survival. For example, glucose, the preferred
carbon source for C. albicans appears to be scarce inside phagocytic cells, but is accessible in
the bloodstream. Several research groups, including ours have focused on the interaction of C.
albicans with host innate immune cells, which serve as the first line of antifungal defense.
Phagocytic cells such as neutrophils and macrophages play a key role in preventing disease
progression by confining C. albicans to site of colonization or infection, and in preventing
dissemination to the bloodstream and tissue invasion. Upon phagocytosis, C. albicans
undergoes a complex transcriptional response that leads to the upregulation of genes involved
in alternative carbon metabolism, including the glyoxylate cycle, gluconeogenesis and βoxidation [57,64,71]. It has been proposed that C. albicans upregulates these pathways in order
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to use a wide variety of non-preferred carbon sources such as fatty acids, acetate and other
gluconeogenic substrates encountered upon phagocytosis. Without the acquisition of essential
nutrients required for growth, C. albicans would not be able to maintain infection. The
importance of the metabolic flexibility displayed by C. albicans is evident, since mutations
affecting key enzymes of alternative carbon metabolic pathways attenuate the virulence of C.
albicans. Due to the importance of alternative carbon metabolic pathways during infection, these
pathways are promising candidates for the development of new anti-fungal drugs [109,110].
The regulation of alternative carbon metabolism in C. albicans appears to be a
combination of the regulatory systems in S. cerevisiae and A. nidulans
To enhance our understanding on how C. albicans may regulate alternative carbon
metabolic pathways, homologs of the well-characterized transcription factors in the nonpathogenic yeast, S. cerevisiae and the filamentous fungus, A. nidulans have been identified in
our lab. Although the metabolic machinery is essentially conserved among different yeast
species, variations in the regulatory networks confer phenotypic differences between them
[129]. Current data indicates the mode of transcription-based regulation in C. albicans is
significantly different from yeast and although some aspects appear more analogous to
filamentous fungi, specific adaptations in C. albicans may contribute to its ability to survive in
harsh microenvironments. C. albicans has homologs of the S. cerevisiae CAT8 and ADR1
proteins, which correspond to FacB and AmdX in A. nidulans and are known to regulate
gluconeogenesis, the glyoxylate cycle, and ethanol utilization. In contrast to S. cerevisiae and A.
nidulans, deleting these genes in C. albicans does not confer a phenotype [83]. Furthermore,
the transcription factors Oaf1p and Pip2p, which regulate genes involved in fatty acid oxidation and peroxisome biogenesis in S. cerevisiae are lacking in both A. nidulans and C.
albicans. In A. nidulans, the FarA and FarB proteins are responsible not only for regulating fatty
acid -oxidation and peroxisome biogenesis, but also the glyoxylate cycle. It has become
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apparent that C. albicans has a more integrated regulatory network than S. cerevisiae and
displays more similarities to regulatory networks in A. nidulans. According to Ramirez and
Lorenz, 2009 [83], C. albicans cannot afford to have periods of metabolic inactivity if it is to
prevail against the host’s immune response. In order to counteract immune attack, it must be
able to rapidly adapt to hostile environments such as those provided by the macrophage
intracellular milieu, where there it encounters limited nutrients. Being able to rapidly assimilate
multiple non-preferred carbons sources may make the difference between life and death. The
different environmental pressures faced by the S. cerevisiae and C. albicans may have resulted
in metabolic gene expression differences between species.
CTF1 regulates fatty acid metabolism and glyoxylate cycle genes
Recently, the C. albicans transcription factor CTF1 has been identified and characterized
based on its homology to the known A. nidulans transcripiton factors FarA and FarB [83]. Gene
deletion of CTF1 results in a mild, but significant decrease in virulence. Northern blot analysis
revealed CTF1 is required for the regulation of genes involved in fatty acid β-oxidation, the
glyoxylate cycle, and peroxisome biogenesis [83]. In S. cerevisiae, the transcription factors Oaf1
and Pip2 control the expression of broad range of genes that are involved β-oxidation or
peroxisomal biogenesis. Although CTF1 is significantly different from Oaf1 and Pip2, it has a
similar function to these factors since it regulates a wide array of genes required for fatty acid
degradation. Based on Northern Blot analysis, the induction of some of these genes in the
presence of fatty acids has been shown to be either partially dependent or entirely dependent
on CTF1 regulation [83]. Global transcription profiling using microarray is a powerful approach
to gain insight into the mode of regulation of a transcription factor under different conditions,
such in the presence of different carbon sources. Microarray analysis derived from wild-type vs.
ctf1Δ/Δ mutant strains grown in glucose or oleate revealed CTF1 coordinates the expression of
a large set of genes (217 genes) [Ramírez, MA and Lorenz, MC unpublished data]. This large
CTF1 regulon consists of genes required for fatty acid catabolism, gluconeogenesis, and the
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glyoxylate cycle, as well as glucose transport and a few genes involved in other cellular
processes including the stress response. Consistent with previous Northern blot analysis,
some of the genes were identified as being partially dependent or entirely dependent on CTF1
regulation. It was surprising to find that 60% of the genes either lack homology to those found
in other organisms or their homologs have not been characterized. Many of these genes are
fungal specific and may represent genes that are important for C. albicans pathogenicity making
them potential candidates for development of antifungal drugs.
To gain insight into the interplay between transcription factors and cis-acting sequences
that equip C. albicans with the metabolic flexibility necessary for disease progression, we have
focused on CTF1 and two of its regulatory target genes, FOX2 and ICL1. Identifying and
characterizing regulatory motifs within CTF1 co-regulated genes, FOX2 and ICL1 is important to
increase the current knowledge on the regulatory mechanisms that govern alternative carbon
metabolism at the transcriptional level. Previous Northern blot results generated in our lab
[75,83], have been confirmed in this study. The endogenous expression of FOX2 and ICL1
genes is repressed in the presence of glucose, whereas their expression in the presence of
acetate and oleate is relatively rapid. To identify cis-acting sequences important for the
regulation of FOX2 and ICL1, a combination of bioinformatic analysis and promoter deletion
analysis was employed. 1000 bp 5’ of the translational start and systematic 100 bp deletions of
each gene were fused to the GFP reporter and analyzed for reporter expression in wild-type
strains and strains lacking CTF1 using Northern blot analysis and fluorescence microscopy.
FOX2-GFP and ICL-GFP reporter expression was not detected in glucose-containing media.
These data confirms previous Northern blot [75,83] and transcript profiling results [107] that
identified both FOX2 and ICL1 as glucose-repressed genes. In addition, a carbon-source
dependent expression of FOX2 and ICL1 was evident since FOX2-GFP and ICL1-GFP reporter
strains were fluorescent in media containing acetate or oleate. In the absence of CTF1, FOX2 is
no longer induced, but it is still subject to derepression. These results are consistent with
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previous Northern analysis [75,83]. However, the results obtained for ICL1-GFP reporter strains
are less clear. Northern blot data generated in our lab [83] showed CTF1 is not required for the
expression of ICL1 in the presence of acetate. Therefore, it was surprising to find that the ICL1GFP reporter expression was significantly reduced in the absence of CTF1. Future experiments
are needed to resolve the discrepancies seen between previous Northern results and current
GFP reporter data for ICL1.
The CCTCGG motif is a cis-regulatory element important for control of the fatty acid βoxidation gene, FOX2
In A. nidulans, the cis-acting sequence (CCTCGG) has been shown to be required for
fatty acid regulation and binding of both FarA and FarB target genes. This motif is present
within the FOX2 and ICL1 promoters and is a candidate sequence for fatty acid CTF1dependent regulation and binding. To determine its relevance in C. albicans, the CCTCGG
motif found within the FOX2 promoter was deleted or mutagenized and fused to the GFP
reporter for fluorescence analysis. In this work, we have identified the CCTCGG motif as
necessary for control of the fatty acid β-oxidation, FOX2 gene. Previous Northern analysis of
wild-type strains grown in glucose, acetate and oleate showed expression of CTF1 only in the
presence of oleate. This suggests FOX2 is only induced by CTF1 in the presence of oleate.
However, deleting or mutagenizing the CCTCGG motif results in a significant reduction in
FOX2-GFP reporter regardless of whether it is grown in acetate or oleate. These results indicate
additional mechanisms are involved. For example, deleting the motif may cause spacing
alterations that disrupt regulation at the chromatin level.
Contrary to what is seen for FOX2, the CCTCGG motif does not appear to be relevant
for ICL1 regulation. Positively regulated site(s) between -1000 and -900 relative to the
translational start appear to be more relevant for ICL1 regulation. Based on the ICL1 promoter
truncation analysis performed in this study, there is no role for one specific motif, but there could
be close mismatches elsewhere that are important for ICL1 regulation. The significance of the
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CCTCGG motif and its complement for ICL1 regulation remains questionable since their
position does not coincide with previously identified regions. Although this study has helped
increase the current knowledge on the regulatory mechanisms that govern alternative carbon
metabolism at the transcriptional level, several unanswered questions remain. 1) What are the
additional cis-acting sites involved in FOX2 and ICL1 regulation? and 2) Is CTF1 regulation
direct or indirect?
What are the additional cis-acting sites involved in the regulation of FOX2 and ICL1?
Promoter regions are likely to harbor multiple elements that act in a combinatorial
manner thereby complicating the identification of discrete elements. The mechanisms by which
FOX2 and ICL1 are activated by CTF1 seem to be different. Bioinformatic analysis of the
upstream region of FOX2 and ICL1 genes revealed their promoters contain several putative cisregulatory elements for transcription factors found in S. cerevisiae (Sc) and A. nidulans (An).
These include putative sites for ScMig1, ScCat8/ AnFacB, ScAdr1, and AnFarA/FarB.
Consistent with FOX2 being under Mig1 repression and its role in fatty acid metabolism, the
FOX2 promoter harbors several putative Mig1 sites and a single copy of the CCTCGG motif. In
A. nidulans, Hynes et al., 2006 [105] predicted that there are three classes of genes, class I:
genes induced specifically by acetate, class II: genes that are induced by both acetate and fatty
acids and class III: genes that are only induced by fatty acids. Based on our results and the
putative sites found within FOX2 promoters, it appears that FOX2 might be a class III gene,
since it is highly induced in the presence of oleate and is required for fatty acid catabolism.
Increasing evidence indicates that although there is conservation of cis- and transregulatory systems across different fungal species, extensive transcriptional reorganization or
rewiring can lead to highly plastic regulatory networks [130,131]. These can form as a result of
many types of modifications including mutations in cis- regulatory sequences. Changes in
transcription factors, including binding specificity, trans-activating potential, and/or cooperative
binding characteristics can also contribute to transcriptional flexibility [129]. In addition, some
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transcription factors with identical binding specificity and kinetics can regulate genes that are
considerably different, thereby changing the members of a particular regulon [132]. Evidence of
transcriptional rewiring across species has been provided by several studies. For example,
Martchenko et al., 2007, showed that Gal4, a transcription factor that is required for galactose
utilization in S. cerevisiae is instead required for glycolysis in C. albicans [133]. Studies in our
lab have demonstrated that CAT8 and ADR1 have no apparent phenotype in C. albicans
despite having significant sequence similarity to their counterparts in S. cerevisiae. In C.
albicans, CTF1 is the single functional ortholog of the A. nidulans FarA/FarB proteins, which are
known to bind the CCTCGG motif [83]. However, DNA sequences that are relevant in related
fungi may not be functional in C. albicans. The in vivo function of putative cis-acting element
across multiple fungal species can be influenced by several factors including site degeneracy, a
requirement for specific adjacent sequences and changes in transcription binding specificity.
Although the CCTCGG motif is present in both FOX2 and ICL1, it is not equally important for the
regulation of both genes. It is possible that the identification of regulatory sites within the ICL1
promoter may have been complicated by the presence of multiple regulatory sites.
Bioinformatic analysis of the ICL1 promoter showed multiple putative sites for Mig1, Cat8/ FacB,
and AnFarA/FarB. Many of these sequences were found at overlapping positions. Based on
this, I speculate that the regulation of ICL1 is most likely as a result of multiple inputs, unlike
FOX2, whose induction is dependent on the presence of fatty acids. Although, 5’ promoter
deletion analysis is useful in defining the boundaries of a regulatory region, a more refined
deletion and substitution analysis is required to identify all the cis-acting elements involved in
carbon based source regulation.
Is CTF1 regulation direct or indirect?
Genetic data indicates CTF1 is a regulator of fatty acid degradation, yet knowledge of
whether CTF1 regulation is direct or indirect is limited. Since, the CCTCGG motif is a cisregulatory element important for control of the fatty acid β-oxidation, FOX2 gene, gel shift
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assays can be used to determine if FOX2 is a direct target of CTF1. Gel shift assays are
particularly useful for analyzing DNA-protein interactions when using short probes with welldefined elements. Therefore, using a short FOX2 probe containing the CCTCGG motif can be
used. In addition, competition assays using specific competitors (unlabeled wild-type and
mutant probes) can be employed to effectively determine CTF1 binding. I have performed
preliminary gel shift assays using C. albicans whole cell lysates and purified recombinant CTF1
protein from E. coli. A faint band shift was observed when C. albicans lysates were tested
suggesting a binding event is taking place. Additional attempts to detect CTF1 specific binding
events were not successful and further optimization is required. Specific binding events may
have been missed when using protein from C. albicans lysates due to insufficient CTF1 protein
levels. To detect potential specific CTF1 binding events, gel shift assays using a purified CTF1TAP protein can be performed in future experiments. I have created two independent strains
that express CTF1 with the TAP tag at the C-terminus using PCR-mediated homologous
recombination [7] and efforts to purify the protein using the TAP method as described by Lavoie
et al., 2008 [7] are underway in our lab.
Although in vitro approaches performed in F. solani and A. nidulans have been
successful in detecting binding to the CCTCGG motif, this may not be equally feasible in C.
albicans. It is possible that CTF1 itself is regulated by phosphorylation in a context-dependent
manner. Studies in F. solani indicate that phosphorylation correlates with FsCTF1α DNA binding
and transcriptional activity [134]. In vitro gel shift assays and transcription assays revealed the
phosphorylation was required for binding and transactivation capacity of FsCTF1α. In silico
analysis of the CTF1 amino acid sequence revealed multiple putative serine, threonine, and
tyrosine phosphorylation sites. Based on these findings, it is possible that phosphorylation of
CTF1 influences DNA binding and activation of FOX2 and ICL1. In addition, DNA topology and
other transcription factors may influence binding, therefore hindering detection of CTF1-DNA
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complexes in vitro. Chromatin immunoprecipitation followed by high throughput sequencing
(ChIP-Seq) may be required to actually detect in vivo CTF1 binding events.
Promising strategies for the development of antifungal drugs
Several strategies have been proposed for the development of more effective antifungal
drugs. Transcription factor-based therapeutic approaches include creating artificial transcription
factors and the use of small molecules that disrupt DNA binding. However, these approaches
have inherent disadvantages and targeting a particular carbon metabolic pathway as a whole
may be more effective. For example, Simm et al., 2011 [135] have used a cell-based screen to
identify new antifungal drugs that target fungal zinc homeostasis. A similar approach that
targets fatty acid β-oxidation in C. albicans could be used instead. This would involve the use of
a strain that monitors changes in fatty acid utilization. In this study, we have shown that wildtype cells transformed with the FOX2-GFP reporter is repressed in the presence of glucose and
induced in acetate and oleate. Because FOX2 is a key enzyme required for the assimilation of
fatty acids, a cell-based assay using the FOX2-GFP reporter can be used to identify compounds
that inhibit fatty acid β-oxidation. For this assay, reporter cells would be grown in oleate and
treated with test compounds. Fluorescence microscopy analysis would then allow the detection
of compounds that inhibit GFP fluorescence. To facilitate high through-put screening, a multiwell format (e.g. 384 micro-titer plates) would be used in a primary screen of compound libraries
along with positive and negative controls. GFP fluorescence intensity would then be measured
using an automated plate reader. Cells treated with a known compound that inhibits fatty acid βoxidation in C. albicans such as 2-methoxy-4-thia fatty acid (±)-2-methoxy-4-thiatetradecanoic
acid [136] can be used as a positive control, whereas a negative control would consist of
untreated samples. Additional positive controls such as including untransformed wild-type cells
or the addition of glucose to the wells would increase the confidence of the screen. Compounds
that significantly reduce GFP expression would be candidates for further validation tests. A
secondary screen for growth inhibition would allow the identification of potent and specific
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inhibitors of fatty acid β-oxidation and would give insight into compounds’ mode of action. For
the secondary screen, reporter cells treated with candidate compounds would be grown in
glucose, acetate or oleate as the sole carbon source. Compounds found to inhibit FOX2-GFP
expression in the primary screen are expected to inhibit growth in oleate. Growth inhibition in
acetate would suggest the test compound does not directly disrupt fatty acid β-oxidation, but
may be targeting a downstream pathway or enzyme. Additional studies such as microarray
analysis of treated versus untreated cells can be performed to determine the identity of their
targets.
In this study, a combination of bioinformatics and promoter analysis was employed to
determine how CTF1 regulates its target genes FOX2 and ICL1 involved in alternative carbon
metabolism. This study has revealed the CCTCGG motif is relevant for CTF1-dependent
regulation of FOX2, but not for ICL1. However, it is unknown whether CTF1 binds the CCTCGG
motif and further studies are required to determine if CTF1 regulation is direct or indirect. C.
albicans has adapted its metabolic regulatory repertoire resulting in a dynamic response that
allows it to thrive within nutrient poor microenvironments. This study provides insight into the
adaptation strategies at the transcriptional level used by C. albicans. Understanding how these
strategies lead to the metabolic flexibility displayed by C. albicans will be a cornerstone for
future advances in anti-fungal treatments against systemic candidiasis.
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